Ads by Google 

¾åµ­¤Î¹­¹ð¤Ï£±¥ö·î°Ê¾å¹¹¿·¤Î¤Ê¤¤¥Ö¥í¥°¤Ëɽ¼¨¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¿·¤·¤¤µ­»ö¤ò½ñ¤¯»ö¤Ç¹­¹ð¤¬¾Ã¤»¤Þ¤¹¡£

Äã¿ñ±Õ°µ¾É¸õ·²(ǾÀÔ¿ñ±Õ¸º¾¯¾É) 

Äã¿ñ±Õ°µ¾É¸õ·²(ǾÀÔ¿ñ±Õ¸º¾¯¾É)¡¡ÉÕµ­¤È¤Þ¤È¤á
(ÊÜÂǤÁ¤«¤é¤¯¤ëÄã¿ñ±Õ°µ¾É¸õ·²(ǾÀÔ¿ñ±Õ¸º¾¯¾É¡Ë¡ª¡ª)

http://www.npo-aswp.org/shinonaga2.html¡¡¡¦¡¦¡¦1¡Ë
http://members.at.infoseek.co.jp/teizui_file/index.html¡¡¡¦¡¦¡¦2¡Ë
http://homepage2.nifty.com/uoh/rinshou/12low_CCF_volume.htm¡¡¡¦¡¦¡¦¤³¤Î3¤Ä¤ÎHP¤¬¾Ü¤·¤¤¤Ç¤¹¡£3¡Ë¤¬°ìÈÖ¸øÊ¿¤Ç¸¢°Ò¤¢¤ë¡©

 

Äã¿ñ±Õ°µ¾É¸õ·²¤Î¿ÇÃÇ¡¡1¡Ë¤ÎÈ´¿è¡¤2¡Ë3¡Ë¤â»²¾È

 

Ǿ¤ÎMRI¤Ç¤Î½ê¸«¤Ï¤¿¤Ö¤ó´°Á´¤ËÆÃ°ÛŪ¤È¤Ï¸À¤¨¤Þ¤»¤ó¡£¼¨º¶¤¹¤ë½ê¸«¤Ï¿¾¯¤¢¤ë¤±¤É¡£¡¦¡¦¡¦£³¡Ë

Ǿ¤ÎCT¤Ç¤Ï¡¤¤¿¤Ö¤ó¹¹¤ËÆñ¤·¤¤¡£

 

R£É¡Ê¥é¥¸¥ª¥¢¥¤¥½¥È¡¼¥×¡ËǾÁ塦ÀÔ¿ñ¹Ð¥·¥ó¥Á¥°¥é¥à¸¡ºº¤¬¤¢¤ëÄøÅÙÆÃ°ÛŪ¤Ê¸¡ºº¤Ç¤¹¡£¡¡2¡Ë¤Î¸¡ºº¤â»²¹Í
¿ñ±Õ¤ËRI¤±ÆºÞ¤òÃíÆþ¤·¡¤°ìÄê»þ´ÖËè¤Ë¤½¤Îή¤ì¤ò´Ñ¬¤¹¤ë¤³¤È¤Çϳ¤ì¤Ê¤É¤òȯ¸«¤¹¤ë¸¡ºº¤Ç¤¹¡¥ 30ʬ¡¤1»þ´Ö¡¤3»þ´Ö¡¤6»þ´Ö¡¤24»þ´Ö¤È»£±Æ¤ò¹Ô¤¤¤Þ¤¹¡¥ 6»þ´Ö¤Þ¤Ç¤Ï¿²¤¿¤Þ¤Þ¤Çµ¯¤­¤ë¤³¤È¤Ï¤Ç¤­¤Þ¤»¤ó¡¥¤³¤ì¤Ç¿ñ±Õ¤Îϳ¤ì¤È¡¤¤½¤Î¾ì½ê¤¬Ê¬¤«¤ì¤Ð¤·¤á¤¿¤â¤Î¤Ç¤¹¡£

 

£Í£Ò¥ß¥¨¥í¥°¥é¥Õ¥£¡¼ ¡§¿¯½±¤¬¾¯¤Ê¤¯¡¤¥Ø¥ë¥Ë¥¢¤Ê¤É¤ò½ü³°¿ÇÃǤ¹¤ëÌÜŪ¤Ï¤¢¤ë¤±¤É¡¤¤³¤ì¤Ç¿ñ±Õϳ½Ð¤ò¸«¤Ä¤±¤ë¤ÎÆñ¤·¤¤¤È»×¤¤¤Þ¤¹

 

¼£ÎÅÊýË¡¤Ï¡¤¼«²È·ì¹ÅËì³°ÃíÆþ¡Ê¥Ö¥é¥Ã¥É¥Ñ¥Ã¥Á¡Ë¤È¤¤¤¦¤â¤Î¤Ç¡¢¤½¤Î¿ñ±Õ¤¬¤â¤ì¤Æ¤¤¤ëÉôʬ¤Ë¼«Ê¬¤Î·ì±Õ¤òή¤·¹þ¤ó¤Ç¡¤·ê¤òËɤ°¤È¤¤¤¦¤â¤Î¤Ç¤·¤¿¡¥

¤¿¤À¤·¡¤Á´¤Æ¤Î¿Í¤¬¥Ö¥é¥Ã¥É¡¦¥Ñ¥Ã¥Á¤ÇÎɤ¯¤Ê¤é¤Ê¤¤¡£¤Þ¤¿¡¤ÍýÏÀŪ¤Ë¤Ï¿ñ±Õ¤Îϳ¤ì¤Ï¸½ºß¤Ï¤Û¤È¤ó¤É¤Ê¤¤¡ÊRI¥·¥ó¥Á¤Ç¸¡½Ð¤Ç¤­¤Ê¤¤¡Ë¤Î¤Ë¡¤Äã¿ñ±Õ°µ¾É¸õ·²(ǾÀÔ¿ñ±Õ¸º¾¯¾É)¤Ë¤Ê¤Ã¤Æ¤¤¤ë¿Í¤Ïµï¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£
2¡Ë¤ÎÌäÂêÅÀ¤Î¾Ï»²¾È¡£

 

2¡Ë¤Î¼£ÎÅË¡¤Ë¤Ï¡¤¹ÅËì³°»ý³À¸Íý¿©±ö¿åÃíÆþË¡¡Ê£Å£Ã£Ó£É¡Ë¤È¤«¼ê½Ñ¤â½ñ¤¤¤Æ¤¢¤ë¤±¤É¡¤¶Ë¤á¤Æµ©¤Ç¤·¤ç¤¦¡£
2¡Ë3¡Ë¤ËÌôʪ¤äÀ¸³è¾å¤ÎÃí°Õ¤Ë¤è¤ë²þÁ±Ë¡¤¬½ñ¤¤¤Æ¤¢¤ê¤Þ¤¹¡£

 

Áж˴ط¸°Ê³°»¨µ­Ä¢¤Î2¡¤3È֤ε­»ö¤â»²¹Í¤Ë¤·¤Æ²¼¤µ¤¤¡£

 

http://www.nhk.or.jp/hot/onair_old/20060215/20060215a.html#

¤³¤ì¤ÏNHK¤Û¤Ã¤È¥â¡¼¥Ë¥ó¥°¤ÎÊóÆ»¤Î¥µ¥Þ¥ê¡¼¤À¤±¤É¡¤¤«¤Ê¤ê°ìÊýŪ¤Ê»¿À®µ­»ö¤Ë¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£²ò¼á¤ËÃí°Õ¤¬¡£

 

3SÀ¯ºö 

3SÀ¯ºö¤È¤Ï¡¤¥¹¥Ý¡¼¥Ä¡¦¥»¥Ã¥¯¥¹¡¦¥¹¥¯¥ê¡¼¥ó(´Þ¤à±Ç²è¡¦¥Æ¥ì¥Ó±ÇÁü)¤ß¤¿¤¤¤Ç¤¹¤Í¡£
£³£ÓÀ¯ºö/31th March
http://www.ne.jp/asahi/stoned.head/sh-home/kakod/mar204.html
GHQ¤Î°ÕÌ£¿¼¤ÊÀïά¤Ê¤Î¤Í¡£


¡ÖÀïÁ褬½ª¤ï¤Ã¤ÆÄ¾¸å¤Î¤³¤È¤À¤Ã¤¿¡£ÆüËܤòÀêÎΤ·¤¿¥¢¥á¥ê¥«¤Î£Ç£È£Ñ¡¢¤³¤ì¤ÏÆüËܤÎÀï¸å¤ÎÀêÎÎÀ¯ºö¤ò¼Â»Ü¤·¤¿¥Þ¥Ã¥«¡¼¥µ¡¼¤¬Î¨¤¤¤¿ÁÈ¿¥¤À¤¬¤Í¡¢ÆüËܿͤζ¯¿Ù¤ÊÀº¿ÀÎϤ¬Áɤ뤳¤È¤ò¶²¤ì¤¿£Ç£È£Ñ¤¬¡¢¤½¤Î¥¹¥Ô¥ê¥Ã¥È¤ò¹üÈ´¤­¤Ë¤¹¤ë¤¿¤á¤ÎÊýºö¤È¤·¤Æ¹Í¤¨¤¿¤Î¤¬¡Ò£³£ÓÀ¯ºö¡Ó¤È¤¤¤¦¥ä¥Ä¤Ç¤Í¡£


¡¡£³¤Ä¤Î£Ó¡¢Sport¡¢Sex¡¢Screen¤ÎƬʸ»ú¤Î£Ó¤ò¼è¤Ã¤ÆÌ¾¤Å¤±¤¿¤â¤Î¤Ç¤Í¡¢¤Ä¤Þ¤ê¤Ï¡¢¤³¤ì¤«¤é¥¹¥Ý¡¼¥Ä¤È¥»¥Ã¥¯¥¹¤È¥¹¥¯¥ê¡¼¥ó¡Ê±Ç²è¤äTV²èÁü¡Ë¤À¤Í¡¢¤¤¤Þ¤¸¤ã¡¢¥ì¥ó¥¿¥ë¡¦¥Ó¥Ç¥ª¤È¤«DVD¤È¤«¿§¡¹¤Ê¼êÃʤ¬¤Ç¤­¤¿¡£


¡¡¤³¤Î£³¤Ä¤òÂ礤¤Ëή¹Ô¤é¤»¤Æ¤À¤Í¡¢ÆüËܤμã¼Ô¤¿¤Á¤ò¤³¤Î£³¤Ä¤ËÇ®Ãæ¤µ¤»¤ë¤³¤È¤Ç¡¢ÆóÅÙ¤ÈÀ¯¼£¤ä¹ñºÝ¼Ò²ñ¤Î¤³¤È¤Ê¤ó¤«¤Ë´Ø¿´¤ò»ý¤¿¤Ê¤¤¤è¤¦¤Ë¡¢¤¤¤ï¤Ð¡¢Æð¼å¤Ê¥Ü¥±¡¦¥¢¥¿¥Þ¤Ë¤·¤Á¤Þ¤ª¤¦¤È¤¤¤¦»Üºö¡¢¤ï¤¿¤·¤Ë¸À¤ï¤»¤ì¤ÐËÅά¤À¤È»×¤¦¤¬¤Í¡£¤½¤¦¤¤¤¦£³£ÓÀ¯ºö¤¬ÀïÁèľ¸å¤Ë¥¹¥¿¡¼¥È¤·¤¿¤ó¤À¤è¡£¡×


¤Ç¤â¤Í¡¤Êƹñ¼«¿È¤À¤Ã¤Æ£³£ÓÀ¯ºö¤ò¤â¤Ã¤È·ã¤·¤¯¤ä¤Ã¤Æ¡¤ÊƹñÆâ¤Î³¬µé¼Ò²ñ¤È¤«ÉÏÉ٤κ¹¤òʶ¤é¤ï¤½¤¦¤È¤·¤Æ¤¤¤ë¤è¤¦¤Ë¸«¤¨¤ë¡£


TV¡¤¥Þ¥¹¥³¥ß¡¤¥¤¥ó¥¿¡¼¥Í¥Ã¥È¤ÎÊóÆ»ÈÖÁȤϡ¤À¯¸¢¤äÂç´ë¶È¤Î°Õ¸þ¤Ë½¾¤ï¤Ê¤¤Ê󯻤ò»þ¤Ë¤¹¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£
¤À¤«¤é¡¤Ã±½ã¤ËGHQ¤¬ÀêÎβ¼ÆüËܤˤ·¤¿»ö¤È¤Ï»×¤ï¤Ê¤¤¡£
¤¢¤ë°ÕÌ£¤Ç¡¤¼«Í³¼çµÁ¤È¤«¡¤Éõ·úÀ©ÅÙ¡¦²ÈÉ×ĹÀ©ÅÙ¤ÎÇ˲õ¡¤Ã˽÷Ʊ¸¢¤Ê¤É¤ò¹­¤á¤¿¤È¤Ï»×¤¦¡£


¥¤¥¹¥é¥à¼Ò²ñ¤È¤«¤Ë¤â£³£ÓÀ¯ºö¤ÏÍ­¸ú¤Ê¤Î¤«¤·¤é¡©

¤¢¤¹¤Î¤³¤È¤ò»×¤¤¤ï¤º¤é¤¦¤Ê 

Á°¤Ë°úÍѤ·¤¿Ìõ¤Ï»ä¤¬Ìõ¤·¤¿¤Î¤Ç¤Ï¤Ê¤¯¡¤¿·¶¦Æ±Ìõ¤È¤¤¤¦Èæ³ÓŪ¿·¤·¤¤Ìõ¤Ç¤¹¡£¸ý¸ìÌõ¤ª¤è¤Ó¿·¶¦Æ±ÌõÀ»½ñ¤Ï¡Êºâ¡ËÆüËÜÀ»½ñ¶¨²ñ¡¢¿·²þÌõÀ»½ñ¤ÏÆüËÜÀ»½ñ´©¹Ô²ñ¤Î½ÐÈÇʪ¤À¤½¤¦¤Ç¤¹¡£

 

http://park10.wakwak.com/~ebible/bsrch/index.html¡¡¡¡¤«¤é¥Þ¥¿¥¤ 6:24 ¡¤ºÇ½é¤Ë°ìÃפ·¤¿Àᤫ¤éϢ³ɽ¼¨¡¡¿·¶¦Æ±Ìõ¤Ç¸¡º÷¤Ç¤­¤Þ¤·¤¿¡£

 

3¼ïÎà¤òÈæ¤Ù¡¤¿·¤·¤¤±Ñ¸ìÌõ¤â¤ß¤Æ¤ß¤Þ¤¹¡£

¸ý¸ìÌõ
¥Þ¥¿¥¤ 6:34 ¤À¤«¤é¡¢¤¢¤¹¤Î¤³¤È¤ò»×¤¤¤ï¤º¤é¤¦¤Ê¡£¤¢¤¹¤Î¤³¤È¤Ï¡¢¤¢¤¹¼«¿È¤¬»×¤¤¤ï¤º¤é¤¦¤Ç¤¢¤í¤¦¡£°ìÆü¤Î¶ìÏ«¤Ï¡¢¤½¤ÎÆü°ìÆü¤À¤±¤Ç½½Ê¬¤Ç¤¢¤ë¡£

¿·¶¦Æ±Ìõ¡§¡¡°ìÈÖ¹¥¤­
¥Þ¥¿¥¤ 6:34 ¤À¤«¤é¡¢ÌÀÆü¤Î¤³¤È¤Þ¤Ç»×¤¤Çº¤à¤Ê¡£ÌÀÆü¤Î¤³¤È¤ÏÌÀÆü¼«¤é¤¬»×¤¤Çº¤à¡£¤½¤ÎÆü¤Î¶ìÏ«¤Ï¡¢¤½¤ÎÆü¤À¤±¤Ç½½Ê¬¤Ç¤¢¤ë¡£

¿·²þÌõ
¥Þ¥¿¥¤ 6:34 ¤À¤«¤é¡¢¤¢¤¹¤Î¤¿¤á¤Î¿´ÇÛ¤Ï̵ÍѤǤ¹¡£¤¢¤¹¤Î¤³¤È¤Ï¤¢¤¹¤¬¿´ÇÛ¤·¤Þ¤¹¡£Ï«¶ì¤Ï¤½¤ÎÆü¤½¤ÎÆü¤Ë¡¢½½Ê¬¤¢¤ê¤Þ¤¹¡£ ¡Ê·Ú¤¹¤®¤À¤±¤É¡¤NIV¤ÎÌõ¤È¤·¤Æ¤Ï¸åȾ¤Ï¤³¤Á¤é¤ÎÊý¤¬Àµ¤·¤¤¤±¤É¡©¡Ë

Matthew 6:34 New International Version (NIV)¡¡Copyright c 1973, 1978, 1984 by International Bible Society
34Therefore do not worry about tomorrow, for tomorrow will worry about itself. Each day has enough trouble of its own.
http://www.biblegateway.com/

 

¤³¤Î±Ñ¸ì¤â·Ú¤¤´¶¤¸¤Ç¤¹¤Í¡£

¸Å¤¤Ìõ¤âõ¤µ¤Ê¤¤¤È¤¤¤±¤Ê¤¤¤«¤â¤·¤ì¤Ê¤¤¤±¤É¡¤¤½¤ì¤Ï¤Þ¤¿¡£

¥Õ¥¡¥Ã¥·¥ç¥ó¥³¡¼¥Ç¥£¥Í¥¤¥È¡¦¥²¡¼¥à 

¤¢¤ë·Ç¼¨ÈĤ˺ܤ»¤¿¤éͽÁÛ¤è¤ê¹¥É¾¤Ê¤Î¤Ç¤³¤³¤Ë¤âºÜ¤»¤Þ¤¹¡£


º£¤Ï¡¤¤¹¤Ã¤«¤ê½Õ¤Ë¤Ê¤Ã¤¿¤«¤é°áÂØ¤¨¤·¤Æ¡¤¥Õ¥¡¥Ã¥·¥ç¥ó¥³¡¼¥Ç¥£¥Í¥¤¥ÈǽÎϤòË᤭¤Þ¤·¤ç¤¦¡£


¥Õ¥¡¥Ã¥·¥ç¥ó¥³¡¼¥Ç¥£¥Í¥¤¥ÈǽÎÏÅÀ¿ô¤¬½Ð¤ëÃå¤»ÂØ¤¨¥²¡¼¥à¤Ç¤¹¡£
¡Ö¥È¥Ã¥×¥¹¡¦¥Ü¥È¥à¥¹¡¦·¤¡¦Ë¹»Ò¡¦¥ì¥Ã¥°¥¢¥¤¥Æ¥à¡¦¥¢¥¤¥Æ¥à¡×¥Ü¥¿¥ó¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¡¢³Æ¥Ñ¡¼¥Ä¤ò¥­¥ã¥é¥¯¥¿¡¼¤Î¾å¤Ë¥É¥é¥Ã¥°¤·¤Æ¤¯¤À¤µ¤¤¡£ ºÎÅÀ¥Ü¥¿¥ó¤ò²¡¤¹¤È·ë²Ì¤¬¤Ç¤Þ¤¹¡£
http://www.gifu-fashion.com/game.htm
Àº¿ÀǯÎ᤬Ä㤤¤È¤«¹â¤¤¤È¤«¤è¤ê¡¤¥Õ¥¡¥Ã¥·¥ç¥ó¥³¡¼¥Ç¥£¥Í¥¤¥È¤Îɾ²ÁÅÀ¿ô¤¬Ä㤤ÊýÍî¤Á¹þ¤ß¤Þ¤¹¡£


»ä¤Ï¥¤¥ó¥Á¥­¤·¤Æ3²ó¥È¥é¥¤¤·¤¿¤é¡¤50¡¤62¡¤82ÅÀ¤Ç¤·¤¿¡£¤½¤Îɾ²ÁÅÀ¿ô¤È¥³¡¼¥Ç¥£¥Í¥¤¥È¤Î½ÐÍè¤Ï¤¢¤Þ¤êÈæÎ㤷¤Æ¤¤¤ë¤è¤¦¤Ë»×¤¨¤Ê¤¤¤Î¤¬¤Á¤ç¤Ã¤ÈÉÔËþ¤Ç¤·¤¿¡£

¾ã³²Ç¯¶âÀ©Å٤ˤĤ¤¤Æ 

¾ã³²Ç¯¶âÀ©Å٤ˤĤ¤¤Æ
http://www2.ocn.ne.jp/~fannie/nenkin.html#Anchor153153
http://www.city.amagasaki.hyogo.jp/web/contents/info/city/city03/Hokensho/Seishin/nenkin/nenkin.htm
£±¡¥¾ã³²Ç¯¶â¤ÎÂоݤȤʤë¼ç¤ÊÀº¿À¼À´µ¡§Àº¿ÀʬÎöÉ¡¦í¯¤¦¤ÄÉ¡¦ÈóÄê·¿Àº¿ÀÉ¡¦¤Æ¤ó¤«¤ó¡¦ÃæÆÇÀ­Àº¿ÀÉ¡ʥ¢¥ë¥³¡Ý¥ë¾É¡¦°ì»À²½ÃºÁÇÃæÆÇÅù¡Ë¡¦´ï¼ÁÀ­Àº¿ÀÉÂ¡ÊÆ¬Éô³°½ý¸å°ä¾É¡¢Ç¾±ê¸å°ä¾É¡¢¿Ê¹Ô¤Þ¤Ò¡¢Ï·Ç¯Àº¿ÀÉ¡¢Ç¾·ì´É·Ï¼À´µÅù¡Ë¡¦ÃÎŪ¾ã³²¤Ê¤É¤¬¤¢¤ê¤Þ¤¹¡£

 

Àº¿À¾ã³²¼ÔÊÝ·òÊ¡»ã¼êÄ¢
http://www.pref.wakayama.lg.jp/prefg/050300/050301/gyomu/techo/tetyou,32jyou.htm

 

¾¤Ë¤â¤¢¤ë¤±¤É¡¤Æñ¤·¤¤Ê£»¨¤ÊÀ©ÅÙ¡£
http://www.shougainenkin.com/index.html
http://allabout.co.jp/finance/nenkin/subject/msub_syougai.htm

 

¤Ç¤â¡¤í¯¤¦¤ÄɤÏÅý¹ç¼ºÄ´¾É¤Ë¼¡¤¤¤Ç½Å¾É¤ÎÀº¿À¼À´µ¤È¤µ¤ì¤ë¤«¤é¤Á¤ã¤ó¤È¥ê¥¹¥È¥¢¥Ã¥×¤µ¤ì¤Æ¤¤¤ë¡£

ˡΧ¤¬¤«¤ï¤Ã¤Æ¤³¤¦¤·¤óɬÍס£

¥±¥Í¥¹¡¦¥¢¥í¡¼¤Î°ìÈ̲ÄǽÀ­ÄêÍý 

¡ä¡ÖÀµÄ¾¤Ë¹Ôư¤¹¤ì¤Ð¡¢¼«Ê¬¤ËÍ­Íø¤Ë¤Ê¤ë¡£ÆÁ¤Ë¤Ê¤ë¡£¡×

 

¡§¤³¤ì¤Ï¥±¥Í¥¹¡¦¥¢¥í¡¼¤Î°ìÈ̲ÄǽÀ­ÄêÍý¤Ë¤è¤Ã¤Æ¡¤¤½¤Î¤è¤¦¤Ê¼Ò²ñ¤Î¹½ÃÛ¤ÏÉÔ²Äǽ¤Ç¤·¤ç¤¦¡£

http://www.res.otemon.ac.jp/~murakami/lecture-note06.htm
̱¼ç¼çµÁ¤ÎºÇÄã¸ÂÈ÷¤¨¤ë4¤Ä¤Î¸øÍý¤òËþ¤¿¤·¤Æ¤¤¤ë¤È¡¤2¿Í°Ê¾å¤Î¹½À®°÷¤«¤é¤Ê¤ë¼Ò²ñ¤Ç3¤Ä°Ê¾å¤ÎÁªÂò»è¤Î¼Ò²ñŪ·èÄê¤ò¹Ô¤¦¤È¸øÍý1-4¤òËþ¤¿¤»¤Ê¤¤¤È¤¤¤¦¤â¤Î¤Ç¤¹¡£¤è¤êÀµ³Î¤Ë¤Ï¸øÍý1-3¤«¤é¸øÍý4¤ÎÈÝÄê¡ÊÆÈºÛ¼Ô¤Î¸ºß¡Ë¤¬Æ³¤«¤ì¤ë¤Î¤Ç¤¹¡£¤Á¤ç¤Ã¤ÈÈéÆù¤À¤±¤É¡£

http://netwind.jugem.cc/?eid=97
¥»¥ó¤Î¶¯°ú¤Ê½¤ÀµË¡¤â¤¢¤ë¤±¤É¡¤¤½¤Î¤è¤¦¤ÊÀ»¿Í¤¬¸½¤ï¤ì¤ë¤«¤·¤é¤Í¡©¤Õ¤Ä¤¦¤ÎÀ¯¼£¤Ç¤Ï»Ù»ýÊìÂΡʽ¡¶µ¤½¤Î¾¡Ë¤Î°Õ¸«¤ËµÕ¤é¤¨¤Ê¤¤¤«¤é¡£

 

¤³¤Î¾¤Ë¤âÅêɼ¤Î¥Ñ¥é¥É¥Ã¥¯¥¹¤È¤«¤¤¤í¤¤¤í¤¢¤ë¤«¤é¡¤Â¿¿ô·è¤È¤«Ì±¼ç¼çµÁ¤È¤«µõ¤·¤¤¤À¤±¤è¤Í¡£

²Ê³Ø¤ÎÀ¤³¦¤Ê¤é¡¤¿¿Íý¤Ï»ö¼Â¤Ç¾ÚÌÀ¤µ¤ì¤ë¤³¤È¤¬Â¿¤¤¤±¤É¡¤¼Ò²ñ²Ê³Ø¤Ç¤Ï¤½¤Î»ö¤ÏÊݾڤµ¤ì¤Ê¤¤¤·¡¤Â¿¿ô·è¤¬¿¿Íý¤Ë¤Ê¤ë¤È¤Ï¤È¤Æ¤â»×¤¨¤Ê¤¤¤Í¡£

ÂпͶ²ÉݤȤ¤¤¦¸Å¤¤ÉÂ̾ 

ÂпͶ²ÉݤȤ¤¤¦¤Î¤Ï¸Å¤¯¤«¤éÆüËܤǻȤäƤ¤¤¿ÉÂ̾¤Ç¤¹¤±¤É¡¤¤½¤ì¤¬¹ñºÝʬÎà¤Ë¤¢¤ë¼Ò²ñÉ԰¾㳲¡ÊSAD)¤Ë¤Û¤ÜƱ¤¸¤È¹Í¤¨¤é¤ì¤Æ¤¤¤Þ¤¹¡£
http://www.fuanclinic.com/byouki/yobou1.htm
http://www.fuanclinic.com/byouki/a_06.htm
http://www.fuanclinic.com/byouki/menu_a.htm#syakai



¤¤¤í¤¤¤í¤Ê¹ñ¤ÎÀº¿À²Ê°å¤¬¤Ð¤é¤Ð¤é¤ËÉÂ̾¤ò¤Ä¤¯¤ë¤ÈÀ°Íý¤¬¤Ä¤«¤Ê¤¤¤Î¤Ç¡¤¤Ê¤ë¤Ù¤¯ÉÂ̾¤Ï¹ñºÝʬÎà¤Ç¤¢¤ëDSM-­¸¤«ICD-10¤Ç¤¢¤é¤ï¤·¤Þ¤¹¡£
¤½¤Î°ÕÌ£¤Ç¤Ïí¯¤¦¤ÄɤÏÁжËÀ­¾ã³²¤Ë¤Ê¤ê¡¤¤Ï¤Ã¤­¤ê¤·¤¿¡¤í¯ÉÂÁ꤬¤Ê¤¤¾ì¹ç¤Ê¤é¡¤Áж˭¶·¿¤Ë¤Ê¤ê¤Þ¤¹¡£
ICD-10¤ÏDSM-IV¤è¤ê¸Å¤¤¤Î¤ÇÁжËI ¤ÈII¤Î¶èÊ̤¬¤Ê¤¯¤Æ¡¤ÁжËÀ­¾ã³²¤Î¾ì¹ç¤Ï¤³¤Î¶èÊ̤ϤȤƤâ½ÅÍפʤΤǡ¤ICD-10¤è¤êDSM-IV¤ò»È¤¦¤Ù¤­¤Ç¤¹¡£
SAD¤Ï¿¤¯¤ÎÉ԰¾㳲¤Ë£±¤Ä¤Ç¡¤É԰¾㳲¤ÈÁжËÀ­¾ã³²¤Ï¹çÊ»¤¹¤ë¤³¤È¤¬¤¢¤ë¤±¤É¡¤¤ä¤äÊѤï¤Ã¤¿É·¿¤Ë¤Ê¤ë¤È»×¤¤¤Þ¤¹¡£
http://m2fazam.hp.gaiax.com/thing/02/136540/
http://m2fazam.hp.gaiax.com/thing/01/139840/



¤¤¤ï¤æ¤ëí¯¾õÂ֤λþ¤Ë¡¤ ¾åµ¡·ù¤Î¡Ê¹¬¤»¤Ê¡Ëí¯¤À¤±¤Ç¤Ê¤¯¡¤ÉÔµ¡·ù¤Ê¥¤¥é¥¤¥é¤¹¤ëí¯¤Ë¤Ê¤ë¿Í¤â¤¤¤Þ¤¹¡£
ƱÍͤˡ¤¤¦¤Ä¾õÂ֤λþ¤Ë¡¤¥¤¥é¥¤¥é¤·¤Æ¤¸¤Ã¤È¤·¤Æ¤¤¤é¤ì¤Ê¤¤Ýµ¤Ë¤Ê¤ë¿Í¤â¤¤¤Þ¤¹¡£
¤³¤Î£²¤Ä¤Ï¡¤Ê¶¤é¤ï¤·¤¤¤³¤È¤â¤¢¤ê¤Þ¤¹¡£


¿ç̲¾ã³²¿ÇÎŤΥ³¥Ä¤ÈÍî¤È¤··ê 

Ãæ»³½ñŹ¤Î¡Ö¿ç̲¾ã³²¿ÇÎŤΥ³¥Ä¤ÈÍî¤È¤··ê¡×¤È¸À¤¦ËܤòÆÉ¤ó¤Ç¤¤¤Þ¤·¤¿¤é¡¤ÁáÄ«³ÐÀä˴ط¸¤¹¤ë¤«¤â¤·¤ì¤Ê¤¤Ê¸¾Ï¤¬¤¢¤ê¤Þ¤·¤¿¡£

¤â¤·Ä¶Ã»»þ´ÖºîÍÑ·¿¤Î¿ç̲Ìô¡Ê¥¢¥â¥Ð¥ó¡¤¥Ï¥ë¥·¥ª¥ó¤Ê¤É¡Ë¤ò»È¤Ã¤Æ¤¤¤ë¤Ê¤é¡¤Ï¢ÍѤ¹¤ë¤È¿ç̲Ìô¤Ë¤è¤ëÁáÄ«³ÐÀ䬵¯¤­¤ë¤é¤·¤¤¤Î¤Ç¤¹¡£
ÂнèË¡¤Ï¡¤1¡Ë¿ç̲Ìô¤òÃæ»ß¤·¤Æ¤·¤Þ¤¦¤«¡¤2¡ËÃæ»þ´Ö¤¢¤ë¤¤¤ÏĹ»þ´ÖºîÍÑ·¿¿ç̲Ìô¤Ë¤¤¤Ã¤¿¤óÊѹ¹¤¹¤ë»ö¤Ç¤·¤¿¡£



¾ÉÎãÄ󼨡¡í¯¤¦¤Äɽ÷À­
ÉÔ̲¡ÊÆþ̲º¤Æñ¡Ë¤òÁʤ¨¤Æ¡¤¥¢¥â¥Ð¥ó7.5mg¤ò½èÊý¤µ¤ì¤ë¡£
1½µ´Ö¸å¡¤Æþ̲¾ã³²¤Ï²þÁ±¤µ¤ì¤¿¤¬¡¤ÁáÄ«³ÐÀäòÁʤ¨¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£
¿ç̲»þ´Öû½Ì°Ê³°¤Ëí¯É¤ξɾõ¤Ï¤Ê¤«¤Ã¤¿¤±¤É¡¤ÉÔ̲¾É¾õ¤òɽ¸½Ë­¤«¤ËÀ¹¤ó¤ËÁʤ¨¤ëÍͤ«¤é¡¤í¯ÉÂÁê¤Î»Ï¤Þ¤ê¤ò¹Íθ¤·¤Æ¡¤¥³¥ó¥È¥ß¥ó20mg¤ò̲Á°¤ËÄɲä·¤¿¡£
¤³¤ì¤Ë¤è¤êÁáÄ«³ÐÀäβþÁ±¡¤Ä«Êý¤ÎÃæÅÓ³ÐÀøå¤ÎºÆÆþ±¡¤â¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£
¤½¤ì¤Ç¡¤ÁáÄ«³ÐÀäÏí¯ÉÂÁê¤Î¤Î½é´ü¥µ¥¤¥ó¤È¹Í¤¨¡¤Ì²Á°¤À¤±¤Ç¤Ê¤¯¥³¥ó¥È¥ß¥ó¤ò110mg¤Þ¤ÇÁýÎ̤·¤Æ¤¤¤Ã¤¿¡£



¤È¤³¤í¤¬¡¤ÁáÄ«³ÐÀäϰ­²½¤·¡¤9:30PM¤ËÆþ̲¤·¤Æ¤â¡¤1-2»þAM³ÐÀä·¡¤¤½¤Î¸å¤â°ì¿ç¤â¤Ç¤­¤º¡¤Ã뿲¤â½ÐÍè¤Ê¤¤¾õÂ֤ˤʤä¿¡£



ÉÔ°ÂŽ¥¶ÛÄ¥¤Ç¤¸¤Ã¤È¤·¤Æ¤¤¤é¤ì¤Ê¤¯¤Ê¤ê¡¤µÞ´µ¤È¤·¤ÆÍ象¤·¤¿¡£
¥³¥ó¥È¥ß¥ó¤ÎÉûºîÍѤΥ¢¥«¥·¥¸¥¢¤ò¹Í¤¨¤Æ¡¤¥»¥ë¥·¥ó10mgÀÅÃí¤Ë¡¤¥Ô¥ì¥Á¥¢¤ò80mgÅêÍ¿¤·¤¿¤¬¸ú²Ì¤¬¤Ê¤«¤Ã¤¿¡£



¤½¤³¤ÇĶû»þ´ÖºîÍÑ·¿¿ç̲Ìô¤ÎÉûºîÍѤÈȽÃǤ·¤Æ¡¤¥¢¥â¥Ð¥ó¤òÃæ»ß¤·¡¤Âå¤ï¤ê¤ËĹ»þ´ÖºîÍÑ·¿¤Î¥À¥ë¥á¡¼¥È¤òÅêÍ¿¤·¤Æ¡¤É԰¤ˤϥ»¥ë¥·¥ó10mg¤ÎÀÅÃí¤òÍѤ¤¤¿¡£



¤½¤Î¸å¤Ï¿ç̲Ìô¤Ê¤·¤Ë¡¤9:00PM¤«¤é6:00AM¤Þ¤Ç°ÂÄꤷ¤ÆÌ²¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£



¤³¤Î·ë²Ì¡¤í¯É¤ÎÉÔ̲¤Ë¤Ï¥¢¥â¥Ð¥ó¤ÏÎÏÉÔ­¤È¤«¡¤ÂÑÀ­¤¬À¸¤¸¤¿¤È¤¤¤¦²ÄǽÀ­¤ÏÈÝÄꤵ¤ì¤¿¡£



µ¡½ø
Ķû»þ´ÖºîÍÑ·¿¿ç̲Ìô¤ò10Æü°Ê¾åÏ¢ÍѤ¹¤ë¤È¡¤ËܿͤÎÄ«µ¯¾²Á°¤Î³ÐÀòó¿ô¤ÎÁý²Ã¤Î¼«³Ð¤Ê¤·¤Ç¤â¡¤¿ç̲ǾÇȸ¡ºº¤ò¹Ô¤¦¤È¡¤ÁáÄ«¤Îû»þ´Ö³ÐÀä¬Áý²Ã¤¹¤ë»ö¤¬ÃΤé¤ì¤Æ¤¤¤ë¡£



Ķû»þ´ÖºîÍÑ·¿¿ç̲Ìô¤Ï¡¤°ìÆü¤Î´Ö¤Ëwashout¤µ¤ì¤Æ¤·¤Þ¤¤¡¤ËèÄ«¡¤¿ç̲Ìô¤ÎΥæ¾É¾õ¤ò°ú¤­µ¯¤³¤¹¤È¹Í¤¨¤é¤ì¡¤¤½¤ì¤¬ÁáÄ«³ÐÀäÎÁʤ¨¤Ë¤Ê¤ë¤È¡¤¹Í¤¨¤ë¤Î¤Ç¤¹¡£



¼£ÎÅË¡
1¡Ë¸¶°ø¤ÎĶû»þ´ÖºîÍÑ·¿¿ç̲Ìô¤ò»ß¤á¤ë»ö¤Ç¤¹¤±¤É¡¤¶¯ÅÙ¤ÎÉÔ̲¤¬2ÆüÄø¤Ïɬȯ¤·¡¤´µ¼Ô¤ËÉéô¤¬Â礭¤¤¡£
2¡Ë¤½¤³¤Ç¡¤¤¤¤Ã¤¿¤óĹ»þ´Ö¤¢¤ë¤¤¤ÏÃæ»þ´ÖºîÍÑ·¿¿ç̲Ìô¤ËÊѹ¹¤¹¤ë»ö¤¬Â¿¤¤¡£
3¡ËÁáÄ«³ÐÀäÀ¤±¤Ç¤Ê¤¯¡¤É԰¶ÛÄ¥¤Ê¤É¤¬Ç§¤á¤é¤ì¤ë»þ¤Ï¡¤¥»¥ë¥·¥ó5mg¡¤Í¼¡¦Ì²Á°¤Ë1¾û¤º¤Ä¤Ê¤É¤òÄɲ乤롣
¾ì¹ç¤Ë¤è¤Ã¤Æ¤Ï¥»¥ë¥·¥ó10mgÀÅÃí¤Ç¤¹¡£2Æü¡¼¿ôÆü¤ÇÊÒÉÕ¤¯È¦¤Ç¤¹¡£
4¡ËÆüÃæ¤Î̲µ¤¤ä¡¤Ã¦ÎÏ´¶¤¬½Ð¤ë¾ì¹ç¤¬¤¢¤ë¤«¤é¡¤Ìô¤ÎÄ´À°¤Ï¤³¤Þ¤á¤Ë¤¹¤ë¡£


 


 


¤Á¤ç¤Ã¤ÈÆñ¤·¤¤°å³Ø½ñ¤Îʸ¾Ï¤Ç¤¹¤±¤É¤³¤ó¤Ê¶ñ¹ç¤Ç¤¹¡£°ìÉô²þÊÑ¡£


more...

ǾÀÔ¿ñ±Õ¸º¾¯¾É 

¸òÄÌ»ö¸Î¸å¤Î¤à¤ÁÂǤÁ¾É¤¬¤¤¤Ä¤Þ¤Ç¤â¼£¤ê¤Ë¤¯¤¤¾ì¹ç¤Ë¡¤¤É¤³¤«¤ÎTV¤ÇÄã¿ñ±Õ°µ¾É¸õ·²¡ÊǾÀÔ¿ñ±Õ¸º¾¯¾É¡Ë¤Î»ö¤¬¤¢¤ë¤ÈÊüÁ÷¤·¤Æ¤¤¤Þ¤·¤¿¡£Ãµ¤·¤¿¤é¡¤Æñ¤·¤½¤¦¤À¤±¤ÉÅö»ö¼Ô¤Î½ñ¤¤¤¿¾Ü¤·¤½¤¦¤ÊHP¤¬¤¢¤Ã¤¿¤Î¤ÇºÜ¤»¤Æ¤ª¤­¤Þ¤¹¡£¤³¤Îɵ¤¼«ÂΤ¢¤Þ¤ê°åÎŦ¤Ë¤âÎɤ¯ÃΤé¤ì¤Æ¤¤¤Ê¤¤¤è¤¦¤Ç¤¹¡£

http://members.at.infoseek.co.jp/teizui_file/index.html


NHK-TV¤Ç¤·¤¿¡£http://www.nhk.or.jp/hot/onair_old/20060215/20060215a.html#¡¡¡£

 

¤Ç¤â4/28/06¤Î½µ´©Ä«Æü¤Î¡Ö̾°å¤ÎºÇ¿·¼£ÎÅ¡×p110¤ò¤è¤ó¤À¤é¡¤¡Ö³°½ýÀ­·ÛÉô¾É¸õ·²¡×¤È¤¤¤¦¤Î¤¬¡¤¿·¤·¤¤¥à¥ÁÂǤÁ¾É¤Î³µÇ°¤À¤½¤¦¤Ç¤¹¡£¤³¤ì¤Ë¤Ï¿´ÍýŪÍ×ÁǤ¬±Æ¶Á¤¹¤ë¤Î¤ÇSNRI¤Î¥È¥ì¥É¥ß¥ó¤¬Í­¸ú¤À¤½¤¦¤Ç¤¹¡£

 

¡Ö¿ñ±Õ¸º¾¯¾É¡×¤Ï¤Þ¤À¸¦µæÃʳ¬¤Ç¨ÃÇ¤Ï´í¸±¤È¤Î¤³¤È¤Ç¤·¤¿¡£

³°½ýÀ­·ÛÉô¾É¸õ·² 

¡Ö³°½ýÀ­·ÛÉô¾É¸õ·²¡×¤È¤¤¤¦¤Î¤¬¡¤¿·¤·¤¤¥à¥ÁÂǤÁ¾É¤Î³µÇ°¤Ç¤¹¡£¤³¤ì¤Ë¤Ï¿´ÍýŪÍ×ÁǤ¬±Æ¶Á¤¹¤ë¤Î¤ÇSNRI¤Î¥È¥ì¥É¥ß¥ó¤¬Í­¸ú¤À¤½¤¦¤Ç¤¹¡£4/28/06¤Î½µ´©Ä«Æü¤Îµ­»ö¡£


¤Õ¤Ä¤¦¤ÎÁíÀâ¡£SNRI¤Î»ö¤Ê¤ó¤«½ñ¤¤¤Æ¤¤¤Ê¤¤¡£
http://hilltp-c.hp.infoseek.co.jp/whiplash.htm


http://www.npo-aswp.org/shinonaga2.html
ÉԻ׵Ĥʥڡ¼¥¸¡£¤³¤³¤Þ¤Ç½ã¿è¤ËÄã¿ñ±Õ°µ¾É¸õ·²¡ÊǾÀÔ¿ñ±Õ¸º¾¯¾É¡Ë¤ËÂǤÁ¹þ¤á¤Ê¤¤¡£

¡äËýÀ­ÈèÏ«¾É¸õ·²¡ÊCFS)¤ÈÄã¿ñ±Õ°µ¾É¸õ·²¤Î¾É¾õ¤Ë¶¦ÄÌÅÀ¤¬Â¿¤¤¤³¤È¤¬ºÇ¶á¤ï¤«¤Ã¤Æ¤­¤Þ¤·¤¿)
¡ä(¹â¼¡Ç¾µ¡Ç½¾ã³²¤È¿ÇÃǤµ¤ì¤¿Êý¤âÄã¿ñ±Õ°µ¾É¸õ·²¤Î²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹)


¡§¤³¤ì¤â¥Õ¡¼¥ó¡©
ËýÀ­ÈèÏ«¾É¸õ·²¡ÊCFS)¢âÀþ°Ý¶ÚÄ˾ɸõ·²¡ÊFMS)¢âËýÀ­EB¥¦¥¤¥ë¥¹´¶À÷¡Ê¤½¤Î¾¤Î¥¦¥¤¥ë¥¹´¶À÷¤Ç¤â¤¤¤¤¡Ë¤Ç¤âËýÀ­¥¦¥¤¥ë¥¹´¶À÷Àâ¤Ï¤Û¤ÜÈÝÄꤵ¤ì¤¿¤È»×¤¦¡£


¢â³°½ýÀ­·ÛÉô¾É¸õ·²


¢âF45.4»ý³À­¿ÈÂÎɽ¸½À­áÖÄ˾㳲¡ÊICD-10)¡¤ÅöÁ³¤³¤ì¤Ë¤Ï¡¤DSM-?¤Ë¤âÁêÅö¤¹¤ëÉÂ̾¤¬¤¢¤ê¤Þ¤¹¡£


Diagnostic criteria for Pain Disorder
A. Pain in one or more anatomical sites is the predominant focus of the clinical presentation and is of sufficient severity to warrant clinical attention.
B. The pain causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
C. Psychological factors are judged to have an important role in the onset, severity, exacerbation, or maintenance of the pain.


307.80 Pain Disorder Associated With Psychological Factors
307.89 Pain Disorder Associated With Both Psychological Factors and a General Medical Condition
Pain Disorder Associated With a General Medical Condition¡Êonly¡Ë¡§¤³¤Î¾ì¹ç¤ÏÀº¿À¾ã³²Ì¾¤Ë¤Ê¤é¤Ê¤¤¤Î¤Ç?¼´¤Ëµ­ºÜ¤¹¤ë¡£
Acute: duration of less than 6 months
Chronic: duration of 6 months or longer


ËýÀ­áÖÄˤȤ¦¤Ä¡§ÆÉ¤à¤Î¤ªÁ¦¤á¡£¥Õ¥í¥¤¥È¤«¤éSNRI¤Þ¤Ç½Ð¤Æ½Â¤¤¡£
http://www.nisseikyo.or.jp/home/mental/2/02_m09/mental_200209_03.html


¾å¤ÎÊüÁ÷¤Î¾¶Ï¿¤ò¤ß¤Æ¤â¤é¤¦¤È¡¤Ê¬¤«¤ë¤è¤¦¤Ë¡¤ËýÀ­áÖÄˤ˹³¤¦¤ÄÌô¤¬Í­¸ú¤Ê¤Î¤Ï¸Å¤¯¤«¤éÃΤé¤ì¤Æ¤¤¤Þ¤·¤¿¡££±¤Ä¤ÎÀâÌÀ¤Ï¡¤¹³¤¦¤ÄÌô¤Ë¤ÏÄˤߤËÂФ¹¤ë¿À·Ð·Ï¤Î´¶ÅÙ¤òÆß¤¯¤¹¤ë¡ÊÄˤßïçÃͤò¤¢¤²¤ë¡ËºîÍѤ¬¤¢¤ë¤¿¤á¤«¡¤¿ïȼ¤¹¤ë¤¦¤Ä¾õÂ֤βþÁ±¤Î°Ù¤Ë¿¾¯Äˤߤ¬¤¢¤Ã¤Æ¤âµ¤¤Ë¤·¤Ê¤¤¤è¤¦¤Ç¤­¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¤È¸À¤ï¤ì¤Æ¤¤¤Þ¤¹¡£


http://www.tvk.ne.jp/~junkamo/new_page_423.htm
ËýÀ­áÖÄË¡¡¡ÊÆÃ½¸¡¡¿ÈÂÎɽ¸½À­¾ã³²¡Ë
http://homepage2.nifty.com/uoh/zutsuu/280manseitsuu.htm
http://www.shiga-med.ac.jp/~koyama/analgesia/pain-classification.html


¿ÈÂÎɽ¸½À­¾ã³²¤È¸À¤¦¤Î¤Ï¡¤Àο´¿È¾É¤È¸À¤ï¤ì¤¿¤â¤Î¤È¤Û¤ÜƱ¤¸¤Ê¤Î¤Ç¤·¤¿¡£

SSRI¤ÎÇ¥¿±´í¸±À­ 

SSRI¤ÏÇ¥¿±Ãæ¤Ë¤½¤ìÄø´í¸±¤Ç¤Ê¤¤¤À¤í¤¦¤È»×¤ï¤ì¤¿¤Î¤Ç¤±¤É¡¤¥Ñ¥­¥·¥ë¤À¤±Ç¥¿±Ãæ¤ËÉþÍѤ·¤¿¾ì¹ç¤Ë¿·À¸»ù¤Ë°Û¾ï¤¬Â¿¤¤¤È¸À¤¦³°¹ñ¤è¤ê¤ÎÊó¹ð¤¬¤¢¤ê¤Þ¤¹¡£
http://www.info.pmda.go.jp/go/pack/1179041F1025_2_10/

¡Ö³°¹ñ¤Ë¤ª¤±¤ë±Ö³ØÄ´ºº¤Ë¤ª¤¤¤Æ¡¢Ç¥¿±Áá´ü1/3¤ËËܺޤòÅêÍ¿¤µ¤ì¤¿Éؿͤ¬½Ð»º¤·¤¿¿·À¸»ù¤Ç¤ÏÀèÅ·°Û¾ï¡¢ÆÃ¤Ë¿´·ì´É·Ï°Û¾ï¡Ê¿´¼¼Ëô¤Ï¿´Ë¼Ãæ³Ö·ç»Åù¡Ë¤Î¥ê¥¹¥¯¤¬Áý²Ã¤·¤¿¡£¤³¤Î¤¦¤Á1¤Ä¤ÎÄ´ºº¤Ç¤Ï°ìÈ̽¸ÃĤˤª¤±¤ë¿·À¸»ù¤Î¿´·ì´É·Ï°Û¾ï¤ÎȯÀ¸Î¨¤ÏÌó1%¤Ç¤¢¤ë¤Î¤ËÂФ·¡¢¥Ñ¥í¥­¥»¥Á¥ó¡Ê¥Ñ¥­¥·¥ë¡ËÇøÏª»þ¤ÎȯÀ¸Î¨¤ÏÌó2%¤ÈÊó¹ð¤µ¤ì¤Æ¤¤¤ë¡£¡×


¡ÖÇ¥¿±Ëö´ü¤ËËܺޤòÅêÍ¿¤µ¤ì¤¿Éؿͤ¬½Ð»º¤·¤¿¿·À¸»ù¤Ë¤ª¤¤¤Æ¡¢¸ÆµÛÍÞÀ©¡¢Ìµ¸ÆµÛ¡¢¥Á¥¢¥Î¡¼¥¼¡¢Â¿¸ÆµÛ¡¢¤Æ¤ó¤«¤óÍÍȯºî¡¢¿¶Àï¡¢¶Ú¶ÛÄ¥Äã²¼Ëô¤Ïж¿Ê¡¢È¿¼Íж¿Ê¡¢¤Ô¤¯¤Ä¤­¡¢°×»É·ãÀ­¡¢»ý³Ū¤Êµã¤­¡¢ÓÏ̲¡¢·¹Ì²¡¢È¯Ç®¡¢ÄãÂβ¹¡¢Ó®Æý¾ã³²¡¢ÓÒÅÇ¡¢Äã·ìÅüÅù¤Î¾É¾õ¤¬¤¢¤é¤ï¤ì¤¿¤È¤ÎÊó¹ð¤¬¤¢¤ê¡¢¤³¤ì¤é¤Î¿¤¯¤Ï½Ð»ºÄ¾¸åËô¤Ï½Ð»º¸å24»þ´Ö¤Þ¤Ç¤Ëȯ¸½¤·¤Æ¤¤¤¿¡£¤Ê¤ª¡¢¤³¤ì¤é¤Î¾É¾õ¤Ï¡¢¿·À¸»ù²¾»à¤¢¤ë¤¤¤ÏÌôʪΥæ¾É¾õ¤È¤·¤ÆÊó¹ð¤µ¤ì¤¿¾ì¹ç¤â¤¢¤ë¡£¡×


¢Í¤³¤ì¤ÏÇ¥¿±Ëö´ü¤Ë°û¤ó¤Ç¤¤¤ë¤È¡¤½Ð»º¸å¤Ë¿·À¸»ù¤¬¥Ñ¥­¥·¥ë¤ÎΥæ¾É¾õ¤òµ¯¤³¤¹¤Ã¤Æ¤À¤±¤ÎÏäǤ¹¡£Â¾¤Î¹³ÉÔ°ÂÌô¡¤¿ç̲Ìô¤Ç¤â¤ª¤­¤Þ¤¹¡£


¾¤ÎSSRI¤Î¥ë¥Ü¥Ã¥¯¥¹¤Î¾ì¹ç
http://www.info.pmda.go.jp/go/pack/1179039F1036_1_15/
¡ÎÇ¥¿±Ãæ¤ÎÅêÍ¿¤Ë´Ø¤¹¤ë°ÂÁ´À­¤Ï³ÎΩ¤·¤Æ¤¤¤Ê¤¤¡¥¤Þ¤¿¡¤Ç¥¿±Ëö´ü¤ËËܺޤòÅêÍ¿¤µ¤ì¤¿Ç¥Éؤ«¤é½ÐÀ¸¤·¤¿¿·À¸»ù¤Ë¤ª¤¤¤Æ¡¤¸ÆµÛº¤Æñ¡¤¿¶À¶Ú¶ÛÄ¥°Û¾ï¡¤áÛÚ»¡¤°×»É·ãÀ­¡¤·¹Ì²·¹¸þ¡¤°Õ¼±¾ã³²¡¤ÓÒÅÇ¡¤Ó®Æýº¤Æñ¡¤»ý³Ū¤Êµã¤­Åù¤Î¾É¾õ¤¬È¯¸½¤·¤¿¤È¤ÎÊó¹ð¤¬¤¢¤ë¡¥¤Ê¤ª¡¤¤³¤ì¤é¤Î¾É¾õ¤Ï¡¤ÌôʪΥæ¾É¾õ¤È¤·¤ÆÊó¹ð¤µ¤ì¤ë¾ì¹ç¤â¤¢¤ë¡¥¡Ï


¥Ñ¥­¥·¥ë¤Ï¶ØÃǾɾõ¤¬¤¢¤ë¤±¤É¡¤ºÇ¾¯¤Î¾ûºÞ¤Ï10mg¤Ç¤¿¤Ö¤ó¤¦¤Þ¤¯2¤Ä¤Ë³ä¤ì¤Ê¤¤¤«¤é¡¤20¤È10mg¾û¤òÂå¤ï¤ê¤Ð¤ó¤³¤Ë°û¤à¤È¤«¡¤20-20-10¤È°û¤ó¤Ç¤¤¤¯¤È¤«¹©Éפ·¤Æ½ù¡¹¤ËÃæ»ß¤¹¤ì¤Ð¤¤¤¤¤Ç¤·¤ç¤¦¡£¤¢¤ë¤¤¤Ï¾¤Î¹³¤¦¤ÄÌô¤òÊ»ÍѤ·¤Ê¤¬¤é¡¤¥Ñ¥­¥·¥ë¤òÈ´¤¯¤Î¤Ç¤ä¤ì¤ë¤«¤â¤·¤ì¤Ê¤¤¡£


Ç¥¿± ¤È ¤¯¤¹¤ê¡§¡¡¸Å¤¯¤Æ»ÈÍѷи³¤ÎŤ¤Ìô¤¬°ÂÁ´¤Ê¤Î
http://www.okusuri110.com/kinki/ninpukin/ninpukin_00top.html
http://www.okusuri110.com/kinki/ninpukin/ninpukin_04-090.html


Ç¥¿±Ãæ¤Ë¤¢¤ï¤Æ¤Æ¹³¤¦¤ÄÌô¤òÀڤꤹ¤®¤ë¤È¡¤¤¦¤ÄɤκÆÇ³¤Î¥ê¥¹¥¯¤¬Áý¤¹¤é¤·¤¤¡£
¤Þ¤¿¡¤½Ð»º¸å¤Î¤¦¤Äɤ¢¤ë¤¤¤ÏÀº¿À¾ã³²¤Ï¡¤½¾Íè¤è¤ê¿¤¤¤é¤·¤¤¡£

¥¢¥ë¥³¡¼¥ë°Í¸¾É¤ÎÌô¡Ê¥¢¥á¥ê¥«¡Ë 

¥¢¥á¥ê¥«¤Ê¤é¥¢¥ë¥³¡¼¥ë°Í¸¾É¤ÎÎɤ¤Ìô¤¬¤¢¤ë¤Î¤Ë¡£

 

May 2, 2006 ? Compared with placebo, naltrexone appears to decrease the likelihood of heavy drinking and significantly increases the number of abstinent days, even without the use of intensive behavioral treatment in abstaining alcohol-dependent individuals. By contrast, acamprosate, used either alone or in combination with naltrexone, failed to improve any drinking outcome measures, a new study, published in May 3 issue of JAMA, indicates.
(JAMA¤Î5/3¹æ¤Ë¡¤naltrexone¤È¤¤¤¦Ìô¤ò»È¤¦¤È¡¤¹ÔưÎÅË¡¤Ê¤·¤Ç¤â¶Ø¼ò´ü´Ö¤¬±äŤ¹¤ë¤È¤¤¤¦µ­»ö¤¬½Ð¤Þ¤·¤¿¡£


http://jama.ama-assn.org/cgi/content/short/295/17/2003?rss=1


Naltrexone was approved by the US Food and Drug Administration for the treatment of alcohol dependence in 1994; 10 years later, acamprosate, which had already been approved for several years in Europe, was also approved in the United States.


http://en.wikipedia.org/wiki/Naltrexone
Naltrexone¤Ï¥¢¥ë¥³¡¼¥ë°Í¸¾É¤ËFDA¤«¤éǧ²Ä¤µ¤ì¤Æ¤¤¤ë¤±¤É¡¤¤³¤ì¤Ï¶½Ì£¿¼¤¤¤³¤È¤Ë¡¤¥â¥ë¥Ò¥Í¼õÍÆÂΤÎÙɹ³Ìô¤Ç¡¤¥â¥ë¥Ò¥ÍÃæÆÇ¤ä¡¤¥¢¥ë¥³¡¼¥ëÃæÆÇ¤Î¼£ÎŤ˻Ȥ¤¤Þ¤¹¡£¤Ç¤â¤³¤ì¼«ÂΤ¬¥â¥ë¥Ò¥Í¤ÎͶƳÂΤÀ¤«¤é¡¤ÆüËÜÀ¯ÉܤÏÉݤ¬¤Ã¤ÆÆþ¤ì¤Æ¤¯¤ì¤Ê¤¤¤Ç¤·¤ç¤¦¡£acamprosate¤È¸À¤¦Ìô¤âǧ²Ä¤µ¤ì¤Æ¤¤¤ë¤±¤É¡¤¤³¤ì¤Ï¥Ù¥ó¥¾¥¸¥¢¥¼¥Ô¥ó¼õÍÆÂΤò¥Ö¥í¥Ã¥¯¤¹¤ë¤è¤¦¤Ç¤¹¡£
¾åµ­¤Î¸¦µæ¤Ç¡¤Naltrexone¤Èacamprosate¤òÈæ³Ó¤·¤Æ¤¤¤ë¤±¤É¸å¼Ô¤Ë¸ú²Ì¤Ï¤¢¤ê¤Þ¤»¤ó¤Ç¤·¤¿¡£Î¾¼Ô¤ÎÊ»ÍѤò¤·¤Æ¤â¡¤Á°¼ÔñÆÈ¤ÈƱ¤¸¤Ç¤·¤¿¡£


·î1²ó¤ÎÃí¼Í¤Î³«È¯
http://www.healthdayjapan.com/healthday/news/h20050405.html¡¡


ÉÂŪÅÒÇî ¤Î¼£ÎÅ¡§¡¡ÌôʪÎÅË¡¤Ï¡¢¤Þ¤À¸¦µæ½é´üÃʳ¬¤Ç¤¹¤¬¡¢naltrexone ¤Ë´Ø¤·¤Æ¤Ï¡¢Æó½ÅÌÕ¸¡Ë¡¤Ë¤è¤ë¼£¸³¤Ç¡¢Í­¸ú¤Ç¤¢¤Ã¤¿¤È¤¤¤¦Êó¹ð(Ladouceur R¤é, 2001)¤¬¤¢¤ê¤Þ¤¹¡£
http://www2.wind.ne.jp/Akagi-kohgen-HP/PathologicalGambling.htm


Naltrexone¤Î¶Ø±ìºîÍѤòÄ´¤Ù¤ë6¥ö·î´Ö¤Î»î¸³¤¬»Ï¤Þ¤Ã¤¿
http://www.biotoday.com/view.cfm?n=6428


Naltrexone¤Ã¤Æ¡¤ËãÌô¡¤¥¢¥ë¥³¡¼¥ë¡¤ÅÒÇ±ìÁð¤È¤¤¤í¤¤¤í¤Ê°Í¸¾É¤Î¼£ÎŤ˻Ȥ¨¤ë¤ß¤¿¤¤¤Í¡£


ML¥ê¥½¡¼¥¹¡§¥¢¥ë¥³¡¼¥ë°Í¸¾É
http://www.medmk.com/mm/add/mp_alcoholism.htm
acamprosate¤Ï¹ñÆâ¤Ç³«È¯¤·¤è¤¦¤È¤·¤Æ¤¤¤ë¤±¤É¡¤naltrexone¤Ï¼ê¤â¤Ä¤±¤Æ¤¤¤Ê¤¤¤ß¤¿¤¤¡£


¥â¥ë¥Ò¥Í¼õÍÆÂΤÎÙɹ³Ìô¤òºî¤í¤¦¤È¤·¤¿¤é¡¤¥â¥ë¥Ò¥Íʬ»Ò¤ò½¤¾þ¤·¤Æ¡¤¥â¥ë¥Ò¥Í¤È¤·¤Æ¤Î³èÀ­¤Ï¤Ê¤¤¤±¤É¡¤¼õÍÆÂΤ˶¯¤¯·ë¹ç¤·¤ÆÂ¾¤Î¥â¥ë¥Ò¥Í¤ÎƯ¤­¤ò¥Ö¥í¥Ã¥¯¤¹¤ë¤è¤¦¤Ë¤¹¤ë¤·¤«¤Ê¤¤¡£
¤½¤¦¤¹¤ë¤È¡¤À½Â¤²áÄø¤Ç¤â¥â¥ë¥Ò¥Í¤ò¥¹¥¿¡¼¥È¤¹¤ëɬÍפ¬¤¢¤ë¤«¤â¤·¤ì¤º¡¤´ÉÍý¤¬ÌÌÅݤˤʤë¤Ç¤·¤ç¤¦¡£
¤Þ¤¿¡¤À½Éʤ«¤é²¿¤é¤«¤ÎÊýË¡¤Ç¡¤½ã¿è¤Î¥â¥ë¥Ò¥Í¤ò¼è¤ê½Ð¤½¤¦¤È¤¹¤ëÇÚ¤â¤Ç¤ë¤«¤â¤·¤ì¤Ê¤¤¡©

 

¤¤¤º¤ì¤Ë¤·¤Æ¤â°Í¸¤òÀ¸¤¸¤ë¥á¥«¥Ë¥º¥à¤ËÆâ°øÀ­¥â¥ë¥Ò¥Í¼õÍÆÂΤʤɤ¬´Ø·¸¤·¡¤¤½¤ì¤ÎÙɹ³Ìônaltrexone¤¬³Æ¼ï°Í¸¾É¤Î¼£ÎŤ˻Ȥ¨¤½¤¦¤È¤¤¤¦¤Î¤ÏÌÌÇò¤¤¤Ç¤¹¤Í¡£

¼ªÌĤê 

¼ªÌĤê¤Î¸¶°ø¤ÏÉÔÌÀ¤Î¤³¤È¤¬Â¿¤¤¤±¤É¡¤

1)¤Þ¤º¡¤¼ªÉ¡²ÊŪ¸¶°ø¤òÄɵ椷¡¤

2)¼¡¤ËÌô¤ÎÉûºîÍѤòÄ´¤Ù¤Þ¤¹¡£
¸þÀº¿ÀÌô¤ÎÉûºîÍѤòÊÒü¤«¤é¤¢¤¿¤ë¤È½Ð¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£

 

¤³¤Á¤é¤Ë¤Þ¤È¤Þ¤Ã¤Æ¤¤¤Þ¤¹¡£
http://homepage1.nifty.com/jibiaka50/miminarigenin.htm
http://www.kamio.org/pamphlet/304.html
http://www.shizuoka-med.jrc.or.jp/php/topic_detail.php?topic_id=29
http://ja.wikipedia.org/wiki/%E8%80%B3%E9%B3%B4%E3%82%8A

 

ÌôºÞÀ­¼ªÌĤ꤬½ñ¤¤¤Æ¤¢¤ê¤Þ¤¹¡£

http://www.tokuyaku.or.jp/tokuyaku/okusuri/topics5.html
Àº¿À¿À·Ð¼£ÎÅÌô ¡§±ö»À¥Á¥¢¥×¥ê¥É¡Ê¥°¥é¥Þ¥ê¡¼¥ë¡Ë¡¤¥Þ¥ì¥¤¥ó»À¥Õ¥ë¥Ü¥­¥µ¥ß¥ó(¥ë¥Ü¥Ã¥¯¥¹¡Ë¡¤±ö»À¥ß¥ë¥Ê¥·¥×¥é¥ó¡Ê¥È¥ì¥É¥ß¥ó¡Ë¡¤¥¯¥í¥Á¥¢¥¼¥Ñ¥à¡Ê¥ê¡¼¥¼¡Ë¡¨ÆëÀ÷¤ß¤Î̾Á°¤¬¡¦¡¦¡¦

 

¥ê¡¼¥¼¡Ê¹³ÉÔ°ÂÌô¡Ë¤Ç¤Ê¤ë¤Ê¤é¡¢¥Ç¥Ñ¥¹¤Ç¤â¤ª¤­¤½¤¦¡©

¥³¥ó¥È¥ß¥ó¤â¹³¥Ò¥¹¥¿¥ß¥óÌô¤Ë»÷¤Æ¤¤¤ë¤«¤éµ¯¤­¤ë¤«¤â¤·¤ì¤Ê¤¤¡©

 

Àº¿ÀŪ¸¶°ø¤ÏºÇ½ªÅª¤Ê¡¤¥¯¥º¥«¥´¿ÇÃǤǤ¹¡£

ƬÄËÂç³Ø 

ƬÄËÂç³Ø¤È¤¤¤¦¡¤Æ¬Äˤ˴ؤ¹¤ëÁí¹ç¥µ¥¤¥È¤¬¤¢¤ê¤Þ¤¹¡£
°ìÈ̤«¤é¡¤ÀìÌç²È¸þ¤±¥ì¥Ù¥ë¤Þ¤Ç¥¤¥í¥¤¥í½Ð¤Æ¤¤¤Þ¤¹¡£
http://homepage2.nifty.com/uoh/


·²È¯Æ¬ÄˤοÇÃǤ¬³Î¤«¤Ê¤é¡¤¥È¥ê¥×¥¿¥óÀ½ºÞ¤Ê¤É¤¬¸ú¤­¤Þ¤¹¡£
http://homepage2.nifty.com/uoh/1234/2shougakkou.htm#·²È¯Æ¬ÄË
http://homepage2.nifty.com/uoh/hosp/03taisaku_cha.htm
http://homepage2.nifty.com/uoh/1234/2shougakkou.htm#¥È¥ê¥×¥¿¥ó


¥È¥ê¥×¥¿¥ó¤Ï¡¤¤¿¤À¤·SSRI¤Ê¤É¤È·ö²Þ¤¹¤ë²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¡£


 

¤â¤·¡¤¤³¤³¤Ç¼ê¤ËÉ館¤Ê¤«¤Ã¤¿¤é¡¤ÄˤߤΥᥫ¥Ë¥º¥à¤Ë´Ø¤¹¤ëÀìÌçŪ¥µ¥¤¥È¤¬¤¢¤ê¤Þ¤¹¡£
¤³¤³¤Ë¾Ò²ð¤µ¤ì¤Æ¤¤¤ë¼£ÎŤÎÁ´¤Æ¤ÏÎ×஥ì¥Ù¥ë¤Ç¤·¤è¤¦²Äǽ¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¤±¤É¡£
http://www.shiga-med.ac.jp/~koyama/analgesia/index.html


¤¿¤À¤·¡¤¤³¤Î¥µ¥¤¥È¤ÎÃí°Õ½ñ¤­¤Ë¤Ï¡¤
1)¤³¤Î¥Õ¥¡¥¤¥ë¤Ï¡¢ÄÃÄˤäÄˤߤˤĤ¤¤Æ³Ø¤Ü¤¦¤È¤·¤Æ¤¤¤ë³ØÀ¸¤µ¤ó¤Î¤¿¤á¤ËºîÀ®¤·¤¿»ñÎÁ¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£
2)¤³¤Î¥Õ¥¡¥¤¥ë¤Ï¡¢ÄÃÄˤäÄˤߤˤĤ¤¤Æ¸¦µæ¤·¤è¤¦¤È¤·¤Æ¤¤¤ë¸¦µæ¼Ô¤Î¤¿¤á¤ËºîÀ®¤·¤¿»ñÎÁ¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£
3)¤³¤Î¥Õ¥¡¥¤¥ë¤Ï¡¢Äˤߤ˶줷¤ó¤Ç¤¤¤ë´µ¼Ô¤µ¤ó¤Î¤¿¤á¤ËºîÀ®¤·¤¿»ñÎÁ¤Ç¤â¤¢¤ê¤Þ¤»¤ó¡£

¤³¤ÎWEB¤Ï¡¢ËèÆüǾºÙ˦¤¬»àÌǤ·¤Ä¤Ä¤¢¤ë»ä¤Î¤¿¤á¤Î¥¤¥ó¥¿¡¼¥Í¥Ã¥È¾å¤Î¥Î¡¼¥È¤Ç¤¹¡£

 

¤·¤¿¤¬¤Ã¤Æ¡¢¤½¤ÎÃíµ­¤Ë¤³¤¦µ­ºÜ¤µ¤ì¤Æ¤¤¤Þ¤·¤¿¡£
¡¡¡öÆâÍÆ¤äɽ¸½¤Ï¤ï¤«¤ê¤ä¤¹¤¤¤â¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£
¡¡¡öžÁ÷¤Ï¼«Í³¤Ç¤¹¤¬¡¢ÆâÍÆ¤Ë¤Ï¡¢ÀÕǤ¤¬¤È¤ì¤Þ¤»¤ó¡£Â¿¤¯¤Î¤Þ¤Á¤¬¤¤¤¬¤¢¤ë¤È»×¤¤¤Þ¤¹¡£
¡¡¡ö¿½¤·Ìõ¤¢¤ê¤Þ¤»¤ó¤¬¡¢¤½¤Î¤Þ¤Á¤¬¤¤¤Ë¤Ï¡¢ÀÕǤ¤¬¤È¤ì¤Þ¤»¤ó¡£


ÌÌÇò¤¤¤³¤È¤Ë»ä¤ÎHP¼«ÂΤ¬Æ±¤¸ÌäÂê¤ò¤«¤«¤¨¤Þ¤¹¡£


»ä¤Ï1)¡Á3)¤ÎÌò¤ËΩ¤Ä¤È»×¤¤¤Þ¤¹¡£

¿ç̲Ìô¤Ë¤è¤ëµï̲¤ê±¿Å¾ 

March 14, 2007
FDA warns sleeping pills can sometimes cause 'sleep-driving'
Lauran Neergaard / Associated Press  article from The Detroit News
http://www.detnews.com/apps/pbcs.dll/article?AID=/20070314/UPDATE/703140450/1004


WASHINGTON -- All prescription sleeping pills may sometimes cause sleep-driving, federal health officials warned Wednesday, almost a year after the bizarre side effect first made headlines when Rep. Patrick Kennedy crashed his car after taking Ambien.


It's a more complicated version of sleepwalking, but behind the wheel: getting up in the middle of the night and going for a drive -- with no memory of doing so.


The Food and Drug Administration wouldn't say exactly how many cases of sleep-driving it had linked to insomnia drugs, but neurology chief Dr. Russell Katz said the agency uncovered more than a dozen reports -- and is worried that more are going uncounted.


Given the millions of prescriptions for insomnia drugs, Katz called the problem rare, and said he was unaware of any deaths. But because sleep-driving is so dangerous -- and there are precautions that patients can take -- the FDA ordered a series of strict new steps Wednesday.


First, the makers of 13 sleep drugs must put warnings on their labels about two rare but serious side effects:


--sleep-driving, along with other less dangerous "complex sleep-related behaviors" -- like making phone calls, fixing and eating food, and having sex while
still asleep.
--and life-threatening allergic reactions, as well as severe facial swelling, both of which can occur either the first time the pills are taken or anytime thereafter.


Next, doctors this week will begin getting letters notifying them of the new warnings.


Later this year, all prescription sleeping pills will begin coming with special brochures called "Medication Guides" that spell out the risks for patients in easy-to-understand language.


Sleep-driving made headlines last May when Kennedy, D-R.I., crashed his car into a security barrier outside the U.S. Capitol after taking Ambien and a second drug, Phenergan, an anti-nausea pill that also acts as a sedative. Kennedy has said he had no memory of the event. He pleaded guilty to driving under the influence of prescription drugs, and was sentenced to court-ordered drug treatment and a year's probation.


Ambien isn't the only insomnia drug that can cause sleep-driving -- any of the class known as "sedative-hypnotics" can, FDA's Katz stressed Wednesday.


To lower the risk of a sleep-driving episode, he advised patients to never take any prescription insomnia drug along with alcohol or any other sedating drug. Also, don't take higher-than-recommended doses of the pills.


"We really want people to know these things can occur, and these sleep behaviors can be perhaps to a large extent mitigated by behaviors the patients can control," he said.


Some of the insomnia drugs may be riskier than others, so FDA also recommended that manufacturers conduct clinical trials to figure that out.


The drugs are: Ambien; Butisol sodium; Carbrital; Dalmane; Doral; Halcion; Lunesta; Placidyl; Prosom; Restoril; Rozerem; Seconal; Sonata.


Fewer than one in 1,000 patients in studies of Ambien reported somnambulism -- a scientific term that includes the sleep behaviors flagged by the FDA -- said Lisa Kennedy, a spokeswoman for manufacturer Sanofi-Aventis SA, who is not related to the congressman. The side effect has remained similarly rare since widespread sales began, she said.

ÂпͶ²ÉݾÉ(µì¾Î¡Ë 

ÂпͶ²ÉݤȤ¤¤¦¤Î¤Ï¸Å¤¯¤«¤éÆüËܤǻȤäƤ¤¤¿ÉÂ̾¤Ç¤¹¤±¤É¡¤¤½¤ì¤¬¹ñºÝʬÎà¤Ë¤¢¤ë¼Ò²ñÉ԰¾㳲¡ÊSAD)¤Ë¤Û¤ÜƱ¤¸¤È¹Í¤¨¤é¤ì¤Æ¤¤¤Þ¤¹¡£
http://www.fuanclinic.com/byouki/yobou1.htm
http://www.fuanclinic.com/byouki/a_06.htm
http://www.fuanclinic.com/byouki/menu_a.htm#syakai


¤¤¤í¤¤¤í¤Ê¹ñ¤ÎÀº¿À²Ê°å¤¬¤Ð¤é¤Ð¤é¤ËÉÂ̾¤ò¤Ä¤¯¤ë¤ÈÀ°Íý¤¬¤Ä¤«¤Ê¤¤¤Î¤Ç¡¤¤Ê¤ë¤Ù¤¯ÉÂ̾¤Ï¹ñºÝʬÎà¤Ç¤¢¤ëDSM-?¤«ICD-10¤Ç¤¢¤é¤ï¤·¤Þ¤¹¡£
¤½¤Î°ÕÌ£¤Ç¤Ïí¯¤¦¤ÄɤÏÁжËÀ­¾ã³²¤Ë¤Ê¤ê¡¤¤Ï¤Ã¤­¤ê¤·¤¿¡¤í¯ÉÂÁ꤬¤Ê¤¤¾ì¹ç¤Ê¤é¡¤ÁжË?·¿¤Ë¤Ê¤ê¤Þ¤¹¡£
ICD-10¤ÏDSM-IV¤è¤ê¸Å¤¤¤Î¤ÇÁжËI ¤ÈII¤Î¶èÊ̤¬¤Ê¤¯¤Æ¡¤ÁжËÀ­¾ã³²¤Î¾ì¹ç¤Ï¤³¤Î¶èÊ̤ϤȤƤâ½ÅÍפʤΤǡ¤ICD-10¤è¤êDSM-IV¤ò»È¤¦¤Ù¤­¤Ç¤¹¡£
SAD¤Ï¿¤¯¤ÎÉ԰¾㳲¤Ë£±¤Ä¤Ç¡¤É԰¾㳲¤ÈÁжËÀ­¾ã³²¤Ï¹çÊ»¤¹¤ë¤³¤È¤¬¤¢¤ë¤±¤É¡¤¤ä¤äÊѤï¤Ã¤¿É·¿¤Ë¤Ê¤ë¤È»×¤¤¤Þ¤¹¡£
http://m2fazam.hp.gaiax.com/thing/02/136540/
http://m2fazam.hp.gaiax.com/thing/01/139840/


¤¤¤ï¤æ¤ëí¯¾õÂ֤λþ¤Ë¡¤ ¾åµ¡·ù¤Î¡Ê¹¬¤»¤Ê¡Ëí¯¤À¤±¤Ç¤Ê¤¯¡¤ÉÔµ¡·ù¤Ê¥¤¥é¥¤¥é¤¹¤ëí¯¤Ë¤Ê¤ë¿Í¤â¤¤¤Þ¤¹¡£
ƱÍͤˡ¤¤¦¤Ä¾õÂ֤λþ¤Ë¡¤¥¤¥é¥¤¥é¤·¤Æ¤¸¤Ã¤È¤·¤Æ¤¤¤é¤ì¤Ê¤¤Ýµ¤Ë¤Ê¤ë¿Í¤â¤¤¤Þ¤¹¡£
¤³¤Î£²¤Ä¤Ï¡¤Ê¶¤é¤ï¤·¤¤¤³¤È¤â¤¢¤ê¤Þ¤¹¡£

ÆüËܹñΩ¤¬¤ó¥»¥ó¥¿¡¼ 

¹ñΩ¤¬¤ó¥»¥ó¥¿¡¼¤ÎHP¤Ç¤¹¡£

http://www.ncc.go.jp/jp/index.html

 

¤¬¤ó¤Ë´Ø¤¹¤ë³Æ¼ï¾ðÊó

http://ganjoho.ncc.go.jp/top.html

 

´ËÏÂ¥±¥¢

http://ganjoho.ncc.go.jp/pub/med_info/care/care_index.html

 

´ËÏÂ¥±¥¢ÉÂÅï¤Î¤¢¤ëɱ¡

http://ganjoho.ncc.go.jp/pub/hosp_info/hospital03/index.html

 

 

 ¤¬¤ó¤Î¾ðÊó¤òõ¤¹¤Û¤¦¤¬¡¤ÁжËÀ­¾ã³²¤Î¤½¤ì¤òõ¤¹¤è¤ê¤Ï´Êñ¤À¤±¤É¡¤Â¿¤¹¤®¤ÆÀµ¤·¤¤¤Î¤òȽÃǤ¹¤ë¤Î¤ÏÆñ¤·¤¤¤Ç¤¹¡£

 

¤Ç¤â³ÆÃϤΤ¬¤ó¥»¥ó¥¿¡¼¤Î¾ðÊó¤ÏÈæ³ÓŪÀµ³Î¤Ç¤¹¡£

 

ÅêÌô¤¬¤¤¤ë¾ì¹ç¤Ï¶á½ê¤Î³«¶È°å¤«ÃϸµÉ±¡¤Ç±ý¿Ç¤·¤Æ¤¯¤ì¤ë¿Í¤òõ¤¹¤«´ËÏÂ¥±¥¢¤òÆÀ°Õ¤È¤¹¤ë¿Í¤òõ¤·¤¿¤é¤¤¤¤¤È»×¤¦¡£

 

Ãϸµ¤Î°å»Õ²ñ¤Ë¿Ò¤Í¤ì¤Ð¶µ¤¨¤Æ¤¯¤ì¤ë¤«¤â¤·¤ì¤Ê¤¤¡©

 

¤¬¤ó¤ÎËö´ü¤È¤Ê¤ë¤ÈÉáÄ̤Υإë¥Ñ¡¼¤µ¤ó¥ì¥Ù¥ë¤Ï¶±¤¨¤ë¤±¤É¡¤°å»Õ¤¬ÉÕ¤¤¤Æ¤¤¤ëˬÌä´Ç¸îÉØ¤Ê¤éÊ¿µ¤¤È»×¤¦¡£

ÆüËÜ¿ç̲³Ø²ñ 

Á°¤Î¥«¥­¥³¤Ç°úÍѤ·¤¿URL¤Î2ÈÖÌܤϡ¤ÆüËÜ¿ç̲³Ø²ñ¤Îµ­»ö¤Ç¤·¤¿¡£
http://jssr.jp/frame_3.html


¿ç̲¤Ë´Ø¤¹¤ë´ðÁÃÃμ±¡¡¤¬»²¹Í¤Ë¤Ê¤ê¤Þ¤¹¡£
http://jssr.jp/kiso/kiso.html


¿ç̲¾ã³²¤Î´ðÁÃÃμ±¡¡ÆÃ¤ËËÜ¿ÀèÀ¸¤Î
http://jssr.jp/kiso/syogai/syogai.html

£É¡¥¿ç̲°Û¾ï¡¡¤µ¤Ã¤­¾Ò²ð¤·¤¿¤â¤Î

£É£É¡¥³µÆü¥ê¥º¥à¿ç̲¾ã³²¡¡ ¡ÊCircadian rhythm sleep disorders¡Ë
http://jssr.jp/kiso/syogai/syogai02.html
¤¿¤Ö¤ó¡¤¤³¤ì¤¬·ë¹½Â¿¤¤¤È»×¤¤¤Þ¤¹¡£


¤ª¤Þ¤±
18¡¡Ä¶Ã»»þ´ÖºîÍÑ·¿¤Î¿ç̲Ìô¤ÎÏ¢ÍѤˤè¤ëÁáÄ«³ÐÀÃ
http://m2fazam.hp.gaiax.com/thing/02/147846/

¥¨¥Ó¥ê¥Õ¥¡¥¤¤¬ÆüËÜȯÇä 

¥¨¥Ó¥ê¥Õ¥¡¥¤¤¬6/8/06ȯÇä

 

ÁжËÀ­´Ø·¸»¨µ­Ä¢¤Ë½ñ¤¤¤¿¤±¤É¡¤½ÅÍפʤΤǤ³¤Á¤é¤Ë¤â¡¤µ­ºÜ¤·¤Þ¤¹¡£
²¿½½Ç¯¤Ë°ìÅٽФ뤫½Ð¤Ê¤¤¤«¤Î²è´üŪ¿·Ìô¤Ç¤·¤ç¤¦¡£
http://m2fazam.hp.gaiax.com/thing/01/145918/

 

¥Ð¥ë¥Í¥Á¡¼¥ë¤Î¹³í¯ºîÍÑ 

¥Ð¥ë¥Í¥Á¡¼¥ë¤Ï¡¤¤ä¤ä°­¤¤°õ¾Ý¤Î¤¢¤ë¹³Àº¿ÀÉÂÌô¤Ç¤¹¤±¤É¡¤ÎϲÁŪ¤Ë¤Ï¥Ð¥ë¥Í¥Á¡¼¥ë200mg¤Ï¥³¥ó¥È¥ß¥ó100mg¤Ç¤¹¡£¤È¤Æ¤âÁ᤯¡¤¥Ñ¡¼¥­¥ó¥½¥ó¾É¾õ¡Ê¿íÂγ°Ï©¾É¾õ¡Ë¤¬½Ð¤ë²ÄǽÀ­¤¬¤¢¤ê¤Þ¤¹¡£¥É¥°¥Þ¥Á¡¼¥ë¤È»÷¤¿¹½Â¤¼°¤Ç¤¹¡£

¥Õ¥§¥Î¥Á¥¢¥¸¥ó·Ï¡Ê¥³¥ó¥È¥ß¥ó¤Ê¤É¡Ë¤ä¥Ö¥Á¥í¥Õ¥§¥Î¥ó·Ï¡Ê¥»¥ì¥Í¡¼¥¹¤Ê¤É¡Ë¤Î¸Å¤¤¥â¥Î¤Ë¤·¤«¡¤í¯¤¦¤ÄɤÎŬ±þ¤¬¤Ê¤¤¤±¤É¡¤¤³¤ì¤Ë¤Ï¤¢¤ë¤Î¤Ç¡¤º£¤Þ¤Ç¤Î¹³Àº¿ÀÉÂÌô¤ËÈ¿±þ¤·¤Ê¤¤¤Ê¤é»î¤¹²ÁÃͤϤ¢¤ê¤Þ¤¹¡£

 

http://www2.cc22.ne.jp/~hiroki/a52.htm
¥ä¥À¥ê¥ó¤Ï¹¥¤­¤Ê¤è¤¦¤Ç¤¹¡£

 

http://www.geocities.co.jp/Bookend-Yasunari/4511/dokuzetumatomonairyou.htm
£±£±¡Ëº£¤É¤­¥Ð¥ë¥Í¥Á¡¼¥ë¤ä¥¨¥ß¥ì¡¼¥¹¤ò»È¤¦°å¼Ô¤ÏÏÀ³°¡£
ÆÇÀ夵¤ó¤Ï¥­¥é¥¤¤ß¤¿¤¤¡£

¿ç̲¾ã³²¤ÎËÜ 

Ãæ»³½ñŹ¤Î¡Ö¿ç̲¾ã³²¿ÇÎŤΥ³¥Ä¤ÈÍî¤È¤··ê¡×¤È¸À¤¦ËܤòÆÉ¤ó¤Ç¤¤¤Þ¤·¤¿¤é¡¤ÁáÄ«³ÐÀä˴ط¸¤¹¤ë¤«¤â¤·¤ì¤Ê¤¤Ê¸¾Ï¤¬¤¢¤ê¤Þ¤·¤¿¡£

¤â¤·Ä¶Ã»»þ´ÖºîÍÑ·¿¤Î¿ç̲Ìô¡Ê¥¢¥â¥Ð¥ó¡¤¥Ï¥ë¥·¥ª¥ó¤Ê¤É¡Ë¤ò»È¤Ã¤Æ¤¤¤ë¤Ê¤é¡¤Ï¢ÍѤ¹¤ë¤È¿ç̲Ìô¤Ë¤è¤ëÁáÄ«³ÐÀ䬵¯¤­¤ë¤é¤·¤¤¤Î¤Ç¤¹¡£
ÂнèË¡¤Ï¡¤1¡Ë¿ç̲Ìô¤òÃæ»ß¤·¤Æ¤·¤Þ¤¦¤«¡¤2¡ËÃæ»þ´Ö¤¢¤ë¤¤¤ÏĹ»þ´ÖºîÍÑ·¿¿ç̲Ìô¤Ë¤¤¤Ã¤¿¤óÊѹ¹¤¹¤ë»ö¤Ç¤·¤¿¡£


¾ÉÎãÄ󼨡¡í¯¤¦¤Äɽ÷À­
ÉÔ̲¡ÊÆþ̲º¤Æñ¡Ë¤òÁʤ¨¤Æ¡¤¥¢¥â¥Ð¥ó7.5mg¤ò½èÊý¤µ¤ì¤ë¡£
1½µ´Ö¸å¡¤Æþ̲¾ã³²¤Ï²þÁ±¤µ¤ì¤¿¤¬¡¤ÁáÄ«³ÐÀäòÁʤ¨¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£
¿ç̲»þ´Öû½Ì°Ê³°¤Ëí¯É¤ξɾõ¤Ï¤Ê¤«¤Ã¤¿¤±¤É¡¤ÉÔ̲¾É¾õ¤òɽ¸½Ë­¤«¤ËÀ¹¤ó¤ËÁʤ¨¤ëÍͤ«¤é¡¤í¯ÉÂÁê¤Î»Ï¤Þ¤ê¤ò¹Íθ¤·¤Æ¡¤¥³¥ó¥È¥ß¥ó20mg¤ò̲Á°¤ËÄɲä·¤¿¡£
¤³¤ì¤Ë¤è¤êÁáÄ«³ÐÀäβþÁ±¡¤Ä«Êý¤ÎÃæÅÓ³ÐÀøå¤ÎºÆÆþ±¡¤â¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£
¤½¤ì¤Ç¡¤ÁáÄ«³ÐÀäÏí¯ÉÂÁê¤Î¤Î½é´ü¥µ¥¤¥ó¤È¹Í¤¨¡¤Ì²Á°¤À¤±¤Ç¤Ê¤¯¥³¥ó¥È¥ß¥ó¤ò110mg¤Þ¤ÇÁýÎ̤·¤Æ¤¤¤Ã¤¿¡£


¤È¤³¤í¤¬¡¤ÁáÄ«³ÐÀäϰ­²½¤·¡¤9:30PM¤ËÆþ̲¤·¤Æ¤â¡¤1-2»þAM³ÐÀä·¡¤¤½¤Î¸å¤â°ì¿ç¤â¤Ç¤­¤º¡¤Ã뿲¤â½ÐÍè¤Ê¤¤¾õÂ֤ˤʤä¿¡£


ÉÔ°ÂŽ¥¶ÛÄ¥¤Ç¤¸¤Ã¤È¤·¤Æ¤¤¤é¤ì¤Ê¤¯¤Ê¤ê¡¤µÞ´µ¤È¤·¤ÆÍ象¤·¤¿¡£
¥³¥ó¥È¥ß¥ó¤ÎÉûºîÍѤΥ¢¥«¥·¥¸¥¢¤ò¹Í¤¨¤Æ¡¤¥»¥ë¥·¥ó10mgÀÅÃí¤Ë¡¤¥Ô¥ì¥Á¥¢¤ò80mgÅêÍ¿¤·¤¿¤¬¸ú²Ì¤¬¤Ê¤«¤Ã¤¿¡£


¤½¤³¤ÇĶû»þ´ÖºîÍÑ·¿¿ç̲Ìô¤ÎÉûºîÍѤÈȽÃǤ·¤Æ¡¤¥¢¥â¥Ð¥ó¤òÃæ»ß¤·¡¤Âå¤ï¤ê¤ËĹ»þ´ÖºîÍÑ·¿¤Î¥À¥ë¥á¡¼¥È¤òÅêÍ¿¤·¤Æ¡¤É԰¤ˤϥ»¥ë¥·¥ó10mg¤ÎÀÅÃí¤òÍѤ¤¤¿¡£


¤½¤Î¸å¤Ï¿ç̲Ìô¤Ê¤·¤Ë¡¤9:00PM¤«¤é6:00AM¤Þ¤Ç°ÂÄꤷ¤ÆÌ²¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£


¤³¤Î·ë²Ì¡¤í¯É¤ÎÉÔ̲¤Ë¤Ï¥¢¥â¥Ð¥ó¤ÏÎÏÉÔ­¤È¤«¡¤ÂÑÀ­¤¬À¸¤¸¤¿¤È¤¤¤¦²ÄǽÀ­¤ÏÈÝÄꤵ¤ì¤¿¡£


µ¡½ø
Ķû»þ´ÖºîÍÑ·¿¿ç̲Ìô¤ò10Æü°Ê¾åÏ¢ÍѤ¹¤ë¤È¡¤ËܿͤÎÄ«µ¯¾²Á°¤Î³ÐÀòó¿ô¤ÎÁý²Ã¤Î¼«³Ð¤Ê¤·¤Ç¤â¡¤¿ç̲ǾÇȸ¡ºº¤ò¹Ô¤¦¤È¡¤ÁáÄ«¤Îû»þ´Ö³ÐÀä¬Áý²Ã¤¹¤ë»ö¤¬ÃΤé¤ì¤Æ¤¤¤ë¡£


Ķû»þ´ÖºîÍÑ·¿¿ç̲Ìô¤Ï¡¤°ìÆü¤Î´Ö¤Ëwashout¤µ¤ì¤Æ¤·¤Þ¤¤¡¤ËèÄ«¡¤¿ç̲Ìô¤ÎΥæ¾É¾õ¤ò°ú¤­µ¯¤³¤¹¤È¹Í¤¨¤é¤ì¡¤¤½¤ì¤¬ÁáÄ«³ÐÀäÎÁʤ¨¤Ë¤Ê¤ë¤È¡¤¹Í¤¨¤ë¤Î¤Ç¤¹¡£


¼£ÎÅË¡
1¡Ë¸¶°ø¤ÎĶû»þ´ÖºîÍÑ·¿¿ç̲Ìô¤ò»ß¤á¤ë»ö¤Ç¤¹¤±¤É¡¤¶¯ÅÙ¤ÎÉÔ̲¤¬2ÆüÄø¤Ïɬȯ¤·¡¤´µ¼Ô¤ËÉéô¤¬Â礭¤¤¡£
2¡Ë¤½¤³¤Ç¡¤¤¤¤Ã¤¿¤óĹ»þ´Ö¤¢¤ë¤¤¤ÏÃæ»þ´ÖºîÍÑ·¿¿ç̲Ìô¤ËÊѹ¹¤¹¤ë»ö¤¬Â¿¤¤¡£
3¡ËÁáÄ«³ÐÀäÀ¤±¤Ç¤Ê¤¯¡¤É԰¶ÛÄ¥¤Ê¤É¤¬Ç§¤á¤é¤ì¤ë»þ¤Ï¡¤¥»¥ë¥·¥ó5mg¡¤Í¼¡¦Ì²Á°¤Ë1¾û¤º¤Ä¤Ê¤É¤òÄɲ乤롣
¾ì¹ç¤Ë¤è¤Ã¤Æ¤Ï¥»¥ë¥·¥ó10mgÀÅÃí¤Ç¤¹¡£2Æü¡¼¿ôÆü¤ÇÊÒÉÕ¤¯È¦¤Ç¤¹¡£
4¡ËÆüÃæ¤Î̲µ¤¤ä¡¤Ã¦ÎÏ´¶¤¬½Ð¤ë¾ì¹ç¤¬¤¢¤ë¤«¤é¡¤Ìô¤ÎÄ´À°¤Ï¤³¤Þ¤á¤Ë¤¹¤ë¡£

 

 

¤Á¤ç¤Ã¤ÈÆñ¤·¤¤°å³Ø½ñ¤Îʸ¾Ï¤Ç¤¹¤±¤É¤³¤ó¤Ê¶ñ¹ç¤Ç¤¹¡£°ìÉô²þÊÑ¡£

more...

¥Ê¥ë¥³¥ì¥×¥·¡¼¡¢¿ç̲»þ̵¸ÆµÛ¾É¸õ·² 

¥Ê¥ë¥³¥ì¥×¥·¡¼¤ä¿ç̲»þ̵¸ÆµÛ¾É¸õ·²¤Î»ö¤Ï¤³¤³¤Ë½Ð¤Æ¤¤¤Þ¤¹¡£
http://www2s.biglobe.ne.jp/~narukohp/3100.html
http://jssr.jp/kiso/syogai/syogai01.html

 

(1)Ìä¿Ç
(2)ÆüÃæ¤Î¿ç̲¥Ý¥ê¥°¥é¥Õ¸¡ºº
(3)½ªÌë¿ç̲¥Ý¥ê¥°¥é¥Õ
¡¡°ìÈÕÃæ¤Î¿ç̲¥Ý¥ê¥°¥é¥Õ¤ò¸¡ºº¤·¤Þ¤¹¡£
(4)¿ç̲Àø»þÈ¿Éü¸¡ºº¡Ê£Íultiple £Óleep £Ìatency £Ôest,¡¡£Í£Ó£Ì£Ô¡Ë
¡¡ÆüÃæ¤Î̲µ¤¤Î¶¯¤µ¤ò¬Äꤹ¤ë¤â¤Î¤Ç¡¢2»þ´Ö¤´¤È¤Ë°ìÆü4²ó30ʬ¤Å¤Ä¿ç̲¥Ý¥ê¥°¥é¥Õ¤ò¬Äꤹ¤ë¤â¤Î¤Ç¤¹¡£
¡Ê5¡Ë³ÐÀðݻý¸¡ºº¡ÊMaintenance¡¡of¡¡Wakefulness¡¡Test,¡¡£Í£×£Ô¡Ë
¡¡Ì²µ¤¤ò²æËý¤Ç¤­¤ëÄøÅ٤θ¡ºº¤Ç¡¢2»þ´Ö¤´¤È¤Ë°ìÆü4²ó30ʬ¤Å¤Ä¿ç̲¥Ý¥ê¥°¥é¥Õ¤ò¬Äꤹ¤ë¤â¤Î¤Ç¤¹¡£
¡Ê6¡Ë·ì±Õ¸¡ºº
¡¡HLA¡Ê¥Ò¥È¼çÍ×ÁÈ¿¥Å¬¹ç¹³¸¶¡Ë¤ò¸¡ºº¤·¤Þ¤¹¡£HLA-DR2¤ÈDQ1¤ÎÍÛÀ­¡¢±¢À­¤òȽÊ̤·¤Þ¤¹¡£ÆüËܿͥʥ륳¥ì¥×¥·¡¼´µ¼Ô¤Ç¤Ï¤Û¤ÜÁ´Îã¤ÇHLA-DR2¤ÈDQ1¤¬ÍÛÀ­¤Ç¤¹¡£

¤³¤Î¤è¤¦¤Ê¸¡ºº¤Ç¡¤¥Ê¥ë¥³¥ì¥×¥·¡¼¤Ï¤Û¤Ü´°Á´¤Ë¿ÇÃǤǤ­¤Þ¤¹¡£
http://www2s.biglobe.ne.jp/~narukohp/3100.html#Q106

 

¤½¤ì¤«¤é¡¤½ªÌë¿ç̲¥Ý¥ê¥°¥é¥Õ¤Ç¡¤Ìµ¸ÆµÛ¤¬¤¢¤Ã¤¿¤ê¡¤·ìÃæ»ÀÁÇ˰ÏÂÅÙ¤¬Äã²¼¤·¤¿¤é¡¤¿ç̲»þ̵¸ÆµÛ¾É¸õ·²SAS)¤È¿ÇÃǤǤ­¤Þ¤¹¡£

ÀΤϡ¤¤³¤Î¤è¤¦¤Ê¸¡ºº¤ò¤ä¤Ã¤Æ¤¯¤ì¤ë¤Î¤Ï¤´¤¯¸Â¤é¤ì¤¿¤±¤É¡¤ºÇ¶á¸òÄ̵¡´Ø¤Ç¤Î»ö¸Î¡ÊSAS¤Î±¿Å¾¼ê¤Ë¤è¤ë¡Ë¤Ê¤É¤«¤é¤³¤Î¤è¤¦¤Ê¸¡ºº¤ò¤·¤Æ¤¯¤ì¤ë¤È¤³¤í¤¬Áý¤¨¤¿¤ß¤¿¤¤¤Ç¤¹¡£

 

í¯¤¦¤ÄÉ¤Τ¦¤ÄÉÂÁꡤµ¨ÀáÀ­´¶¾ð¾ã³²¤Î¾ì¹ç¡¤²á̲¤Ë¤Ê¤ë¤Î¤ÏÈæ³ÓŪ¿¤¤»ö¤Ç¤¹¡£

 

²á̲¤È¤¤¤Ã¤Æ¤â¡¤¥Ê¥ë¥³¥ì¥×¥·¡¼¤È¿ç̲»þ̵¸ÆµÛ¾É¸õ·²¤Ï¾¤ÈÁ´¤¯°ã¤¤¤Þ¤¹¡£

Àº¿ÀÎÅË¡¤ÎÉûºîÍÑ 

Àº¿ÀÎÅË¡¤Ç°ú¤­µ¯¤³¤µ¤ì¤¿´õ»àǰθ¡¡
»×½Õ´ü¤¦¤ÄɤÎÀº¿ÀÎÅË¡¤Î¤ß¤Î¼£Îťȥ饤¥¢¥ë¤Ç´õ»àǰ褬ÁýÂ礷¤¿


Bridge JA, Barbe RP, Birmaher B, Kolko DJ, Brent DA.
Emergent suicidality in a clinical psychotherapy trial for adolescent depression.
Am J Psychiatry. 2005 Nov;162(11):2173-5.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16263860&query_hl=28&itool=pubmed_docsum
¥Õ¥ëÏÀʸ¡¡¡¡http://ajp.psychiatryonline.org/cgi/content/full/162/11/2173


»×½Õ´ü¤Î¤¦¤ÄɤˤĤ¤¤Æ¡¤¤¹¤Ù¤Æ¤Î¹³¤¦¤ÄÌô¤Ë¤Ä¤¤¤Æ´õ»àǰθ¤ä¹Ôư¤ÎÁý²Ã¤ò£Æ£Ä£Á¤Ï·Ù¹ð¤·¤Þ¤·¤¿¡£
¤³¤ÎÃø¼Ô¤é¤Ï¤½¤Î·Ù¹ð°ÊÁ°¤«¤é¤Î¥×¥é¥ó¤Ç¡¤¼ï¡¹¤ÎÀº¿ÀÎÅË¡¤Î¤ß¤Ç¼£ÎŤǡ¤´õ»àǰθ¤Î½Ð¸½¤ÎÉÑÅÙ¤âÄ´¤Ù¤è¤¦¤È¤·¤Æ¤¤¤Þ¤·¤¿¡£


¤½¤ì¤Ê¤ê¤Ë´í¸±°ø»Ò¤Î¤¢¤ë¿Í¡¹¤Ç¡¤122¿Í¤Î»²²Ã¼Ô¤«¤é¡¤107¿Í¤¬»î¸³¤Ë»²²Ã¤·¤¿¡£¥é¥ó¥À¥à¤Ë1)ǧÃÎ¹ÔÆ°ÎÅË¡¡Ê£Ã£Â£Ô¡Ë¡¤2)·ÏÅýŪ¹Ôư²È²ÎÅË¡¡¤3)È󻨼¨Åª»Ù»ýÎÅË¡¡¤¤Î3¼ïÎà¤Ë¿¶¤êʬ¤±¤¿¡£¤Õ¤Ä¤¦12-16¥»¥Ã¥·¥ç¥ó¤ò12-16½µ¹Ô¤¤¡¤¤½¤ì°Ê¸å2-4²ó¤Î¥»¥Ã¥·¥ç¥ó¤ò¿ô¥ö·î¥Ö¡¼¥¹¥¿¡¼¤È¤·¤Æ¹Ô¤Ã¤¿¡£


æÍ¤¿´µ¼Ô¤ò½ü¤­Åö½é´õ»àǰθ¤ò¥¤¥ó¥¿¥Ó¥å¡¼¤ÇÈÝÄꤷ¤¿88¿Í¤«¤é11¿Í¡Ê12.5%¡Ë¤¬¼£ÎÅÃæ¤Ë´õ»àǰθor¹Ôư¤¬½Ð¸½¤·¤¿¡£10¿Í¤Ï·×²è¤Ê¤·¤Î¹Í¤¨¤À¤±¤Ç¡¤1¿Í¤Ï¼«»¦Ì¤¿ë¤ò¤·¤¿¡£8/11(72.5%)¤Ï¼£Îų«»Ï¸å3¥ö·î°ÊÆâ¤Ë¤ª¤­¤¿¡£


·ë¶É¡¤Àº¿ÀÎÅˡñÆÈ¤Ç¤â¡¤¹³¤¦¤ÄÌôÎÅË¡¼£¸³¤ÈƱ¤¸ÄøÅ٤Ρ¤´õ»àǰθor¹Ôư¤¬½Ð¸½¤·¤¿¤È¤¤¤¨¤ë¡£¤³¤ì¤ÏûÊó¤Ç¡¤Ä¾ÀÜ¡¤ÌôʪÎÅˡñÆÈ¡¤¤¢¤ë¤¤¤ÏÌôʪ¡ÜÀº¿ÀÎÅË¡¡¤¤ÈÈæ³Ó¤Ï¤·¤Æ¤¤¤Ê¤¤¤«¤éº£¸å¤Î¸¡Æ¤¤¬Íפê¤Þ¤¹¡£¤Ç¤âÀº¿ÀÎÅË¡¤¬Á´¤¯Ìµ³²¤È¤¤¤¦¹Í¤¨¤Ï´þ¤Æ¤ë¤Ù¤­¤Ç¤·¤ç¤¦¡£


¡ö¤³¤Î·ë²Ì¤Ë¤Ï¿¾¯»×¤¤Åö¤¿¤ëÅÀ¤¬¤¢¤Ã¤Æ¡¤Àº¿ÀÎÅË¡¤Î·ë²Ì¡¤µ¤Ê¬¤¬Îɤ¯¤Ê¤ë¤³¤È¤â¤¢¤ë¤±¤É¡¤ÎÅË¡²È¤Îȯ¸À¤Ê¤É¤Ë¤è¤Ã¤Æ¤Ï¡¤¤«¤¨¤Ã¤Æµ¤Ê¬¤¬°­¤¯¤Ê¤ë¤³¤È¤¬¤¢¤ê¤Þ¤¹¡£»×½Õ´ü¤Î»Ò¶¡¤Ç¤Ï¤³¤ì¤¬¤è¤ê¶¯¤¤¤Î¤À¤È»×¤¤¤Þ¤¹¡£


Àº¿ÀÎÅË¡¤â¤¤¤í¤¤¤í¤¢¤ë¤±¤É¡¤Èæ³ÓŪºÇ¶áȯ㤷¤¿¡¤Ç§ÃÎ¹ÔÆ°ÎÅË¡¡Ê£Ã£Â£Ô¡Ë¤ÈÂпʹط¸¡¼¼Ò²ñ¥ê¥º¥àÎÅË¡¤Ï¡¤ÁжËÀ­¾ã³²¤Ç¤âÉÂÁê¤òÁª¤Ù¤ÐÍ­¸ú¤È¤¤¤ï¤ì¤Þ¤¹¡£
¤·¤«¤·¡¤¤Ï¤Ã¤­¤ê¸À¤Ã¤ÆÁêÅöÍ¥½¨¤Ê¥µ¥¤¥³¥»¥é¥Ô¥¹¥È¤Ç¡¤´µ¼Ô¤ÈÁêÀ­¤¬Îɤ¯¤Ê¤¤¤È¤À¤á¤Ç¤¹¡£
ñ¶ËÀ­¤ÎÂ礦¤Äɤʤ鸦µæ¼Ô¤Ë¤è¤Ã¤ÆÁêÅö½Å¾É¤Ç¤â¹³¤¦¤ÄÌô¤ËɤŨ¤¹¤ë¤È¹ë¸ì¤¹¤ë¿Í¤â¤¤¤Þ¤¹¡£


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=pubmed_DocSum&db=pubmed&cmd=Display&dopt=pubmed_pubmed&from_uid=10401443¡¡¹ë¸ìÇÉ


http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=abstractplus&db=pubmed&cmd=Retrieve&dopt=abstractplus&list_uids=15809408¡¡Æ±¤¸Ãø¼Ô¤Î¥°¥ë¡¼¥×¤Î¿·¤·¤¤¤Î¤Ç¤Ï¡¤¾¯¤·¸À¤¤Êý¤¬¤ª¤È¤Ê¤·¤¯¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£Í¥¤ì¤¿Ç§ÃÎÎÅË¡²È¤Ç¤Ê¤¤¤È¥À¥á¤È½ñ¤¤¤Æ¤¢¤ê¤Þ¤¹¡£